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ABSTRACT

The action of the hypoglycemic compounds, tolbutamide,
chlorpropamide,

me~ahexamide.

at\d phenethylbiguanide, on the

-

biosynthesis of cholesterol haa be. . investigated in vit" with
mevalonate-2-C14 using a rat liver enzyme system containtng
soluble enzymes pzaecipitated betweeD 30...60% (NH4)2S04' microsomes,
NADPH, NADH, and ATP tn 0.1 14 phosphate 'buffer, pH 7.4.

The

results show that the incorporation of mevalonate-2-c14 tnto
cholesterol ia inhibited by all compouada .tudied.

The mmd,mal

inhibition occurs when the concentration of hypoglycemic compound
is 4 x 10""

M.

The marmer in which theae compouada inhibit cholesterol

biosynthesis, however, is quite different.

Phenethylbiguanide

deereas.. the formation of the non-aaponifiable lipids and
choi.,sterol by approximately the same amount from m.evalonate-2-

C14 •

This would ~ly that phenethylbiguanide inhibits the

biosynthesis of cholesterol before the formation of the cholesterol intermediate found :in the tlOll.... sapotlUiable lipid fraction.
This 1s substantiated by the inhibition of squalene formation
from mevalonate-2_C14 • Furthermore, there is an accumulation of
the isoprenola. pre-squalene cholesterol iatermediatea.

phase

cbromatogra~

Reverse

of the 3,S-dinitrobenzoate derivatives of

the alcohols showed that the accumulation of radioactivity was in
the famesol derivative.

It follows that phenethylbigwmide

interrupts the biosynthesis of cholesterol at the. level of the
C1S-isoprenel,

fa~601

pyrophosphate.

'1'he. aryl.aulfanylureas, tolbutamf.de, chlorpropamide, and

metahexami4e. however, are different as regards their effect
the biosyatheaia of cholesterol.

poration of mevalonste-2-C14

O'l\

!hey do not inhibit the incor-

~to ~e non-saponifiable lipid

and

cholesterol by the same magaihde. Startfng with mevalonate-2C14 , there is almost no difference between the non-saponifiable
lipid formed wb_ the aryl sulfonylurea eempounds are pre.ent or
absent froB the tncubation mixture, aDd yet cholesterol biosynthesis 1s inhibited.

When the isoprenels and squalene are iso-

lated, th..-. again is no difference.

Whea, however, lanosterol

was isolated, tibere was a decrease ta its formation corresponding
to t1\e de...... 4tbtained in cholesterol ayathesized from
mevalonate-2-Cl4 • And finally, wheat squalene was iaolated after

aerobic ineubatlcrna. there was an i:rtcreaa. in its formation when
tolbutatd.de was preaent in the f.ncubatiGn adxtul"es.

The increase

in squale1\e fOl'lDaUon from rae.valonate-2-c14 could be explained by
the decrea.. in the bioayntbes1a of cIao1eaterol in the same In-

It foll...,8, therefore, that tolbutamide inhibits
cholesterol biosynthesis from mevalonate-2-Cl4 between squalene
cubations.

and lanosterol. or more precisely, at the cyclization of squalene.
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CHAPl'D. I

TIl! IIOS'DTHISI8

or

CHOLESTIllOL

In 1942. Blocb .DeI Rttt"'", (22) cliscovered that when

isotop1c.lly l.beled .cetic .cid i ••~iD1atered to an ant.al. or
is .deled to the incub.tiOD Mdi.. of tissue prepar.tions. i.otopi
c.lly l.beled chol.. terol

CaD

.ubsequently be extracted fra. tbe

oraana of the ant.al or from tbe ti.aue prep.rations.

It i. now

pos.ible to outline .o.t of the reactions of .terol bio.ynth.. i.
fro. acetate.

The known .equence in tbe for.ation of Chole.terol

frOll .cetate 1a .......r1&ed 111 riaur. 1.
tbr.. phases:

It can b. divided into

1) .eet.t. - ....l ...t •• 2) ....lonat. - squalen••

and 3) squalene - cholesterol.
ACETATE - MlVALORATE

Th. first two .teps in chol.sterol biosyntbesis involve
.ctiv.tion of acet.te to acetyl-Col and condens.tion of the latte
to acetoacetyl-Col..

'!'b. .e

st.,s are ..11 .stablisbed reactions

and involve other ..tabolic pathways besid.s cholesterol biosynth.. is.

th.y involve th. for.ation of ac.tyl adenylat. fro.

acetate and ATP whicb then r ..cts with coea.,.. A to for.
.c.tyl-CoA and AMP.

loth .tep. of th. reactioa are catalysed by

2
TABLE 1

INTERMEDIATES Df CHOLESTEROL BIOSYNTHESIS

Acetate

---+~

Acetyl.CoA

I

S.Phoaphomevalonate

I

5-Diphoaphomavalonate

I

Isopentenyl pyrophosphate

I

Geranyl pyrophosphate

~Dtmethylallyl

pyrophosphate

----+-

CHOLESTEROL

Parnesyl pyrophospbute

/

Squalene

Lanosterol

3

a siDa1e . .,.... acetic tblo1d.nase.

'ftte nat stq_. a COIld_-

satin of acetoac.ty1-eGA with acety1-coA, baa been studied
ext.stv.1y 'lty beID.y (126) and L)'D- (94).

'l'b• • •,.. r.spon-

sible for the r ..ction, HJ«I-CoA-cond.s1D& . .,.., ha. been
partially purified fro. ,.. .st (53).

The process liberate. one

_leeule of eoeDa7IM A, wbieh c. . . from the acetyl and DOt froll
the acetoacetyl aroup, producina 3-bydroxy-3-.ethy1 a1utary1-CoA
(HHC-CoA).
CoA can "

A1Choup the reaction i. not ... 11y rever.ible, HMG-

irreversibly cleaved 'by another . .,.... HMC-CoA

cleavq. . .,.., to ac.toacetate _d Acetyl-CoA (126).

This in

effect produc.. a hydrolYSiS of acetoacetyl-eGA and is tboulht to
produce fr. . acetoacetate in the liver (6).
The coover.loo of HMG-CoA to mevalonic acid by a solub1,
...,.. .yst. bas bea extensively studied by Dun,

Rudn.,., aDd

'_pson (47) (52) (127) ad by Lyaen (91) (9.5).

It is apparentl,

caealysed by • sinale ana,..., HMC-CoA reductase.

POI'

of HNG-Col raduclMl. ODe IIOle of MVa10nate is fonaed.

..,ery _1.
two

_1..

of MDPR are o.d.dlaed, and OIle _le of coena,... A i. r.l......
'l'be . . , . . ccmtaias au 1fhydry 1 &roups ..s.tial for the catalytic
activity.. evldenced 'by the face that the reduction tak.. place
at the thiol-uterlfied earboxy1 p'oup of HMO.

Meva1dle acid

4

FIGURE 1
THE BI OSYNTHE.<i IS OF CHOLESTEROL
A~'I'ATE

1
.;...

2.

CH 3COOacetate

+

CoASH

+

ATP

.;!'.

GH CQ'SCoA
3

+

acetyl-eoA

......
..,...

2 CH3Co.~CoA

CH 3 COCH COSCoA
2

acetoacetyl-CoA

acetyl-GoA

en:3COSCoA
acetyl-CoA

- H11G-CoA

CB3COCH2COS CoA
acetoacetyl-COA

+

+

no, . . CH,3
,c,

H27

~2

()=:C

(}I: 0

t

no

+

,

S-CoA

3-hydroxy-3-methyl-glutaryl-CoA

U'lO
.:.

J-\HP

+

P..p 1

5

HO, ...
C

CR,

,'"2

Ii C" 'moL

2t

0-0t

0-0
,

HO H
mevald1c aci4

which baa been pres___d to be • part of chole.terol hiosynthesi.

" •• ,rov.a 'y Durr

&ad R.ucla4ay (46) not to h. involved.

that th. fr.. aldehyde, 1I8Va1die acid t is DOt

aD

th. f.ct

1DterJledi.te in

the react10a does not preclude the possibility that ..valdle
acid is

aD

1Dt......iat. 1D tbe blosynth.. 1a of cholest.rol.

the possibility that ena,..-bouad ..va1die acld or its
thiGh_iaeetal are iDterMdiat.. still r_1Ds.

The over-all

reaction, therefore. prohaly proceeds 1D a two-st., _ _ar with
aD

eas,..-bound ....ldat. or its tbiah..tacetal belDi _

-.diet. in the reduction.

_,.a.

int.r-

It is appareGt1y catalyzed b, • slnal.

aDd auob reaction. apparectly proceed throuab . .,....

bound iDter.edlat.. (111) (133) (139).
Ttl. strikina feature of thl. reductlon la that it 1.

irreversible.

HMC-CoA redu.ctaa.. whatever the acturc.. is

atereoapecific for the natural optical enantio.orpb (t) of
JIG (85).

"'s far •• it is Imown. ODce . . .alOGic acid ia foraed

()

FIGURE 2

THE BIOSYNTHESIS OF CHOLESTEROL
FORNATION OF MEVALONIC ACID

H02 0OO

2 -

<;U3
<: -

CH2 COSCoA

+ HS ... Enzyme

OK

3-hydroxy-3-methylglutaryl-CaA

,

H

H

H02CCR2 -

~3

~ •
Ott

CH2CH2OH

meval_ic acid

+

HS-E'nzyme

7

eoeu.,.. A 1. no lemael" required for furtber reactiODs.

The

a...... of th... reactlou 18 ...... In rlaur.. 1 and 2.
MEVALOHATE .. SQUALID

The aecond phaa. of the bio.yaCh.. ta of choleacerol
lDvo1v.. .evera1 ...,..tic react10fta which convert ..va1onic acid
to aqua1ene.
The transforation of lIIIVa10Dic acid to uopenteny1
pyropboaphate i. effected by thr.. ATP-dependent at.pa, catalysed
respectiv.ly by mevalonic kina•• (142) (91) (87), ..valonic
pbo.phokiDaa. (18) (71) (21), and a decarboxyla.e (18) (21) (145)
(3) •

Mev.1ODic acid. by th. actioa of ...,a100ic kiD••e and
ATP,

~.

pho.phorylated to yield pbo.phom8valonic acid (141) (125)

(144) • 'lbe ...,.. cat.lysin. thi. reaction . . . . to be

aD

SR-en.,.. aiace it ia inhibited by p-chloro.ercurib. . . .te.
Mevaloa1c kin.ae, • •ther fro. ,ea.t or liver, i. .tareo.pecific
for the natural enantia.orpb (4) of ..valODate juat a. RMC-COA
reduct..e vas atereo.peclfic for (f) HMC-CoA..
When 5..pbo.pbo-(2-C14)~.lonate I, incubated without
ATP, there i. no production of .tero1.
further pboapbory1ation tak.. place.

Thi. aUlleated that a
The eaa,.. c_taly.ina thia

8

reaction haa been parti.lly purified fro. pll liver by Popjak (69)

and catal,... the reversible foraation of '-dlpboaphomevalon.te
trca phosptt-.v.10llate _d Aft (r1pre 3).
equilibria. 11..

011

The polition of the

the slde of the forward reactiOll aDd pes .t

optt.u. r.te in tbe prea_ce of

MI++ lOlls. Aa tbe phospho-

.....10l11c kiDaae react1cm is rever.lble, lt i. evld_t that the
s.ODd pho.phate bond 1ft 5-dlpbo_pbo••valoute 1_ an _erl1 rich
boDCl. prol».l, of the . _ order of _ituel. .. that of ATP.

!b. decarboxyl.s. .yet. i_

_1'.

oOllpl_ aad i.

characteriaed by _everal uau.ual ieatur...
hal ..... partially purified 1»,. Bloch ...

.&1. t

'lbla __, - , which
(21) cat.l,... •

reactlon betweea 5-dipbo• .....,.loaat. and ATP to for. 110penteD,1 pyropho.pbatet CO2, ADP, aacl

P04.

It h •• been IUlle.ted

that the decarboxylation proceed. via. labile phoaphate e.ter,
5-dipbo.pho-3-pbo• .....,.lon.t., .ine. p32 contained 11'1 ATp32
uled 1D the reaction did DOt appear 1a the ilopeoteD,l pyro-

phosphat. (32) (93).

Recefttl, L1acIberl. Y\IaD, deWaard. and

Bloch (88) have obtaiaec:l avid_c. th.t definitely poiatl to . .
iDter.ctlon bet.... the ter.1n.l phosphat. of ATP and the tatiar,
alcobol &rOUP of 5-dipbo.ptt-.valonlc .cld and IUlleat that this
interactlon !acilitat..

c-o

cl••v....

Th. intermediary for.ation
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PIG"uRE 3
THE BIOSYNTHESIS OF'

CHO~TEROL

PHOSPHORYLATION OF HEr-vALONIC ACID

?I2OH
H 0
2

"
/C

H2r

OR
/

+

'at,

002H

mevalonic acid

~2OP03Ha
H 0
2

,
/

C

H2~

/

,

OR

+

CB3

002H
5-phosphomevalORic acid

~

t

ADP

H
OP
f!H2 20 6 3
H20, /OH
C

J:12~

/

" CHs

nOaH

S-dipboaphomevalonic acid

A'fP

10
of a covalent pbo.pbate ••ter, '-pboapbo-'-dipbospboaevalonle
acid, which could •• a... tIM favorable 81x... riered

rin& structure

(Plpre 4, .cb_ .) 1. a poa.1bi11ty, 'but in the absence of

direct evidence alternative fOrallationa earmot 'be ruled out.
The type of traDafer of 0 18 fro. tub.trate to P04 .t
daaonetrated by Bloch .1£

.&1. J

(88) baa been observed :In a number

of A'fP dependent .ynth.... (25) (84) (67) (140). yet in

ftO

case

h.. the . .cb.an1etieally probable phoaphoric eater int......1at.
bea lMlated.

Buchanan.lt.l1., (28) have au.... ted a eoaeerted

mechard.M for nucleophilic d1aplac __t reactionl :lnvolYina thr. .
subltrat.. aDd thr. . reaction producta.

The prOpMed . .chaDi. .

18 applicable to the varioua .ynth.... that are coupl. . to the
el..". .e of ATP to ADP ad P04 eel can he exteaded to the
decarboxyla.e react1. (Flaure 4. sell_ b). with the lIOCIificatioa
that

ODe

of the d1.plae_ _ tl 18 hltra- 1natead of latenaolecular.

Bloch (18). bowver. poillt. out that th1a .till do•• DOt rule out
the iDt. . . .tary foraatiOD of 3-pbolpbo-S-dipbolpbome'lalonlc acid.
The poallbll1Cy that the carboxyl

hydroxyl &rOUP of

p"oup

5·dipbo.~aloaate

ratber than the tertiary

1. attaeked by the

tand.Dal pbolpbate of AD baa b.. fOUDCl to be ialpro1tabla.

11
FIGURE 4

THE BIOSYNTHESIS OF' QiOi.i<;STEROL

l-fECHANISM 01' DECt\RBOXYLATION OF 5-DIPHOSPlIOMEVALONATE

a).

?"2OP206H3
H2C, /G'B3

/C,
l~~

OH

ADP

COr'

5-diphoaphomev.1enic
acid

!

'fA2 OP 20,H3
H20,

+

~C,
H 0
2

+
CH3

{sopentenyl pyrophosphate

b).

5-dipboaphoDlevalon.ic

acid
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Althousb the formation of 180peatenyl pyrophoaphate
and ita incorporatlon into th. aqualene 1I01acule baa been proven
to take place (93). the lDa'DDer 1D which thla tak. . place 18 'till
a aubjec:t of wide r . .earch.
aqual. . _1. .1e the

S1nce at the two ends of the

aroup:1na

(CBS> 2C-CH- appear.. it follow

that an 1aGIariaat1oD of the iaopeteayl pyrophosphate to a

cU..thylallyl Ib:ucture . . .t occur at 80188 at_.

la......

With the

partial purification of the __,.. iaopentea.yl pyrophoaphate

(93). 'tIblch COl1Verta laopenten,l pyrophoaphat. to

d1Mthyla1ly1 pyrophoaphate. the bypath.ala of the 1a_ _1&at1oa
of laopeat_,l pyrophosphate vaa experiMatal1y proven.

Thia

reaction could be .viaioned as beiDa 1Ditiatecl by • protOll

followd ):',

8ft

.IS.1aaeloo of a HCODd proton fr_ the mo1ecul.

aa allow 1D Flaure

.s.

'lhe a)'Debui' of aqual.e proceeda fro. a a . .le. of
co04. .aaciou iDvolvlDl .lectropbllic addition to doubly Nuad
-thy1.. poupa.

Dillethylallyl ,yrophoapbate. in ea

other ....t_e.. 1D wbich • pot_tially ao1oa:l.o

c...

sroup

GO

with

(in chi,

.aterU1ed vith • pyropboapbate) II :I.D the alpha poalt.ion

to • double boad. are .lectrophll1c.

Loa,.f the pyrophosphate

fro. eueA su.atee. . . .,. "cur readily. for tile reault1Da .lec-
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PICURE 5
THE BIOSYNTHESIS OP CHOLESTEROL

ISOPENTENYL PYROPHOSPHATE - GERANYL PYROPHOSPHATE

1. Isomerization of iaopentenyl pyrophosphate to dimethylallyl
pyrophoephate:

••

(II
t

OH2OP206H2
garanyl
pyropboaphate

14
tron-deficient .peel.a 1. ,artlally atab111aad by r.aooence
bet. . . two equlvalent foral
t

t

•

t

(C-C-c)

,
'+
e-G.c
•
t

Aa vaa

at.~'"

+
+ OR-

~c+. c· c

.
t

_-..~

,

Miore, tha all_ type .ub.t_c.. ara .t...,

elactrophl1!c ca.pounda ... could attack a ter.taal .-thyleae

aroup.

'fbl• •lectropllillc: . . . . .u. could occur .1ther vla the

tnt~.di.t.

100 or .. •

b~lec:ular

d1.'l.c....t.

'Dua . .t probabl. flr.t cODd. .at1oll l . .d1q to the

fonaatioD of aqua1. . ,. MCWHD

d~yl.llyl

pyroplloapbat• •nd

laopentan,l pyropbo....t. (92). with the .lilli_tion of pyropboapbate ioD In. the diaathylallyl pynpboaphata (I'lpre 5) ."

carrl.. . . . .c..a of poalt1ve char.a INt at_Illation . , occur

by a1 i eSaatloD of • proton 11v1Da riae to .-reDy1
(92) •

,yr~pbate

III .....71 pyrophoaphat. we have ...1D . . .lactropblilc

r . . . .t. which

call

coact.aaa w1c1a . .tbar _lec\ll. of Uopeat.,l

pyropbo.pb.at. 10 the a_ _ _ _ .a th. coracl• •at1ora of the latter

1.S

with dtmethylallyl pyrophosphate.

Again by stabilization through

eltatnat10n of a proton, the product, farn.ayl pyrophosphate (92),
is obtained (F!aure 6).

It ia not kno1«l whether the two condensations are

cataly.ed by two different eoz,..., 'but the formation of seranyl

and fames,l pyrophosphate. 18 readily d.aonatrated in a liver
enzyme system.

Lynen.t.t..Il. t (93) syntheslzed d1methylallyl and

garanyl pyrophosphate. and obtained the formation of iaranyl and
farn..,l pyrophoaphatea with an enzyme system prepared from y. .at

and frOID soluble supernatants of liver homosenatas.
Farne.yl pyrophosphate, a CIS isoprenoid substanc.,
re8ambl.s squalene tn the fact that a tail to tail condensation
of two molecules would &ive ris. to .qualene.

Although it 1s

still not pos.ible to define preci.ely the reaction sequence in
the biosynthesis of squalene from farn •• yl pyrophosphate, the

poaaible typea of aechanim have been narrowed down.
proposed -.chant.. the following
accounted for:

exper~tal

In any

facts have to be

1) the 10•• of ana H atom from C-l of one

farn.syl pyrophosphate DOlecule. 2) the replacement of this H

atom with the hydride 10n from NADPH; 3) failure of incorporat1oD
of a proton froe vat.. into squalene durinl biosyntheais frOlB

16
Flot.JRE 6

THE BIOSYNTHESIS OF CHOLESTEROL
GERANYI. PYROPHOSPHATE ... NEROLlDYL PYROPHOSPHATE

1, Formation of famesyi pyrophoapbate:

,
CH2 OP 2 0 6H,3

famesyl
pyrophosphate

?i3

R-

~~

Clt3
2. Hypothetical isomerization of tamesyl pyrophosphate to
nerolidyl pyrophoaphate:

~3

R-C-C-CR
, ,
2

o , H/ 0P

ot " "- 0
P03H2

nerolidyl pyrophosphate

17

iaruM),1 pyropbo.pbat. (119). an4 4) the probable partlcipatloD

1'1:'_ th... r.lu1ta PopJak

.IS. .I!.• (119) 4_uc_

fo1low1D, . - - a l featur .. of a . .1.....loa,.thaale.
that

aD

eel

1 . .1 -

"rica1 ps'OC'"

...lolyath.. le.

th.

It 1. clear

. a t ... 1avo1vad 1D th. 1.at

at.. of

OD. of the tw cODden_in, lam..,1

pyropboapbat. _l_ule. ...t ...
fX'. tboa. of th. other.

_Jact to r ..etiou dUferent

!he ro1. of MDPS in the b!08",th.ale

CaI'laot be the reduction of • double bond. for 1D that eveat th.
uptake of • protOD fro. th. lae__t1oa ....1.. .. w11 .1 tbe
tr.lf.r of th. hydrid. :loa &a. IlADPH should have Mcu.ned.

TIt. proe..1

. .y

lavo1.. the 1......1. .t1on of one

farn..yl pyropbOlpb.at. _lHU1. to nerol1d,l pyrop!loapbate aa
h ....... IUII.lted by Cornforth and Popjak (41) (40) and Popjak

(116).

Such an laomerl••t1oa il DOet readl1y envll. .ed ......lnl

dle r . . .1t of aD lac....1 pbo.pIlac. rean. ._ t (r1pr. 6).

a1tboqb leparatlem aDd reattac_ _t of pyropboapbat. 100
Ititut• •other poelib11it,.

COl'l-

By. proe..1 _lopua with the

blo.,.Cheata of . . . .,1 aDd fara. .,l ,:rropbolplaate froa
diaetb.y1allyl _d iaopent.eay1 pyropboepbate t.be two hblt_cea

could oODden••

'-y

a 1NC1eophl11c

proe....

It il IUppoaeci that

the condensation is assisted by the phosphate anion in nerolidol
pyrophosphate and that the cyclic ester (I. shown in Figure 7) ia
the first intermediate, althouJh the

fo~t1on

of intermediate

(II) need not necessarily involve that of the cyclic ester.
Reduction of this intermediate by NADPH with an allylie rearraDzemant may give squalene directly.
An alternative mechanism also postulated by Popjak at

JJ.!.,

(18.5) involves a reaction with methionine which 't«)uld give,

with or without an allylic rearrangement, the sulfonium compounds
(III) and (IV) shown in Figure 8.

The former (III) could be

reduced with NADPfl in the same way as (II), except that no proton
participates.

The reduction of (IV) t not proceeding by way of an

allylic system might be akin to the reduction of a car.bonyl group
by NADPU.

The above mechanisms cover all the known experimental
observation. on squalene biosynthesis from farnesyl pyrophosphate.
The evidence of the enzymatic formation of nerolidol in liver
enzyme systems, however, is not entirely convincing (63) (116).

The conclusion that the reaction 1s a genuine formation of the
nerolidol derivative rests on the appearance of free nero1idol
after hydrolysis of a mixture of polyprenol derivatives with

19

natn\E
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THE BIOSYNTHESIS OP

~OL

HYPOTtIETICAL MECHANISM OF SQtJ.ALENE BIOSYNTHESIS I

~?P206H,

at - OR ..

~-at2R

OR3

(1)

1
(II)

1
squalene

R==

?i3

~3

(H30-at0H2~o-CHCH2-

R'

=:

HPO3
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FIGURE 8
T'I-lE BIOSYtmtESIS OF CHOLESTEROL
HYPOTHETICAL HECHANISM OF SQUALmE BIOSYNTJ:IESIS II

I
SQUALENE

(IV)

...

NADP

C:U3

+ S,

t;U2
b).

(V)

SQUALENE

••- - -

R and rtf == as in Figure 7.

(VI)
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snake v8DOa pbosphat... and also froa th. reductioD of a fr....dried alkaline apeeiMn of th••• d.rivative. with LUIS. in .ther

(117).

Occurrence 10 plant oila of an optically activ. Derolidol

alao s",porta the idea of tb. ena,..tic iaameriaation of a
darivative of fam...l to that of the t.rttuy alcohol nerolidol

(119).

The iao.erlaatl00 probably proceeda .a a ruult of

1Dtemal pboapbate rearrana__t ('lp.re 6). altboqb a. .ratiOll
aIld reattacb.1leat of pyropboapbate loa constitut..

another poa-

sibillty.
Tbe dlscussion ao far aaaUMel that the e1fainat1on of
Ofte H at_ .. a protOll, orl&1na1ly att.acb.ecl t.o e-l of fam..,1
pyropboaphate (or to

e-s

of ..valODate), occurred froa tbat unit

of farueayl pyrophoaphate _ieh waa .ul»jeet to the 1. . . .1aatiOD
to

nerol1cly1 pyrophoaphate.

be

.0.

HCMJVer. thi. need not aee..aarl1y

A••umins qa1n the l_riaatlon of farneayl pyropbo.pbate

.. before, the

rearr&DI~t

of lDterMdiate (V) to a aubatance

coata1Dina the cyclopropane riDl (VI) i. alao a posaibility.
thia caa. the .li.jaation of the hydroaea at.. occurs fro. the
.ide opposite to that conaidered in the previoua .ech. .i ....
Squal_e could tb.a\ aria. f r . the reductive 01..".,. of the
yclopropan. riq tdth I1AJ)PH aDd the ccmcert_ elWaat1.oa of

1ft

the pyropbosphate anion.
SQUALENE .. CHOLISTDOL

there are three plac.. in the ebol•• terol molecule
where a repeatina pattern of live carbon atoaaa appears, containin
acetate . .thyl and carboxyl atome in an i.opentane structure.
This fact was first recognised by Bloch (15'> after dearadation
of the aide chain of chol•• terol biosynthesised from C14.1abeled
aeetatea, and prompted him to revive the old hypotbesu that
.qualene, a d1hydrotriterpene, is an intermediate in ebolesterol
blosynth.. :s.a (16).

The firet experiaent.l proof that .qualen.

••• • part of chol •• terol biogen.ei. ... obtained by Lanadon and

Bloch (86) wbo .howed that .tIU8len8 ••s a1Dthee1sad by rat liver
frOta ac.t.t..

'lb. conver.ion of ....1. . lato aterol baa aiDe.

b• • confined by Mauad.l. Tcben, amd llocb (99) 1Iho obta1Dad the

conv.raion of .qualen_ into lanosterol.
Th. oyeli••tion of acaual.. to lanoaterol 1s cat.lys.d
by the . ..,.. .qu.l• • oxidocycl....

'lb. 1nitiatilll .peel. .

actina on .qualen. is ...aaed to be a o.tiODle oXYI_ .t_ ••• 1.

oat.

Th. • • ..,tion c.... fro. th. f.et that _ _ aev.loole .cid

1. incubated with r.t liver

ru-oa-.t..

nltrol_ only .....1... 1. aynth.a1&ecI.

und.r an ae..ph..-e of
When oXYlen la substituted

2J
~or

111croa_. cbQl. .cerol 18 .'-oat t1ae 081, product that CaD be

i.olated With very little _flUelen_ Min, pr. . .t (118).
The cyc11.atioa of squalene proc.... without tbe

forutloo of _table 1Dt-=-ciia1:U (20) by a CODeereed electrophil1.: ...1t1_, ac...-1eci by rearr_ _ _ t and tera1....ted by
expula10n of • pro"", (49).

A feacure of ebb mecheni_ 1_ a

8l1t1p1. 1: 2 _1ft to electrcm-def1c:.ieat CeDter..
auplaJ: ..cbyl aroupa betweea r1D&. C and

.u

'the two

of lanoaterol bave

botb, it 1a poeCUl.ted, reacheel their final poa:.itioaa by .iaratioa

fraaa

-1abboriDI carbon

_COIla.

1'h1. . .lIDa Chat

aro"p

B of

.....1. . (a. . below) Decoae attached to C-ll of l . .aterol aDd
croup A to C-14.

HO
Squalene

Lanosterol
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This hypotbeaia was

exper~cally

proven in a

brilliant .et of experiments by Cornforth

~!l.,

and Mauadal, Tchen, and Bloch (99).

the data, the process

FrOal

(38) (39) (42a)

waa po.tulated as being a forward eycliaation initiated by the

oxygenated cation lead ins to an electron deficiency at C-20
followed by a cooc.rted backward rearranaement.

One hydrogen

mov. . to C-20, and another to C-l7; a _thyl &roup move. to C-l3,

and another uthyl aroup to C-l..

The hydroa. at position 9 1a

fwlly expelled to fon the double bcm4 in laDostarol.

In otber

worda, the teer.cyclic syst. is foraed before the rearrana-..t.
A detailed -..eh8Diam of this eyeliaaCion i. abown in !'iaura 9.
The cODVeraion of lanoaterol to chol.. terol require.

the r..",al of three _thyl &roup., reduction of the

D. 24-double

bond, and a "shift" of the nuclear double bond frOll position
to poSition ~ '.

~8

The . .chan ism by which the.e chaaa. occur and

the .equence in which they occur are poorly understood at this
tiM.

The controversy centers around the

ar,. . .t 1s whether or

6

24 double bond.

The

DOt the recluct10n of this double bond

occurs early or late 1n the

8 . . .ence.

At the _ _nt, Doth

possibiliti.. appear to be true.
Iloeb .t!. .tl.. (61) (77) have

aaOlm

that 4,4-diMthyl-

2S
FIGURE 9
THE BIOSYNTHESIS OiBOLESTEROL

CYCLIZATION OF SQUALENE

HO
Squalene

HO

HO
Lanosterol
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choleata-8.24-dien-3- iJ-Ol and .,.oaterol (cbol.. ta-8.24-dieaol)
can he biologically cOIlverted to choleatwol.

SteiDbua and

AviaaD (136) (5) have 1deotlfl_ d. . .aterol (chol•• t.-S.24-

d18OO1) 1D rat. and .an after treatment with MER-a"

• hypo-

cboleaterol.aic aubatance. and .hown ita tranafor.atlOft to
eho1eaterol !9. litg.

o.e of the pathwaya. tb.refore. would

cOlltaill acluatve1, compouada viCh a 24,25 double boad 1a tbe

alde ch.ta (Table 2).

the firat of th... reactioaa ia the

oxidative r_v.1 of thr. . . .thyl lroupa fre. lano.terol (62).

The ruction . . . . to proceed via the carboxylic analop.. which
are thea cUtcarboxylatecl to yielel thr. . . .lecu1_ of CO 2 •
,roe..a r84U1r.. _leeular

oxya-

The

ad IfADPR.

The _thy1 p'oup attached to C-14 of lao.tarol 1a

.It.t~ted
(62).

firat, yie1dtna 4,4-dt.8thylcbol.. ta-8,24-dlea-3-

,roc..pou,.

'11le replac _ _ t of hydroa_

coafipratioa.
el~tn.ted

Bloch . .

The two . .thyl

Dext with the prior

Al. t

~.Ol

without cbaDp in

at the 4 poaitioQ are

fo~tion

of '-keto derivativ...

(62) (19) baYe po1Dtecl out that a keto p-oup at

e-3 woulel facilitate the clecarboxylatioD of (

foruel by oxidation of the .ethyl &rOUpa

OIl

a -keto)

acida

C-4.

It i8 not yet k . - _ich of th..e tw p-oupa 18

27
elf.1l.1nated first.

After the removal of the second methyl ,"up,

the keto group at C-l i. apparently reduced again yielding
zymosterol (chol.sta-8,24,dienol).
twO

double bond ".hifts" from

Zymaseerol could then underao

D 9,10

to

de8lllOsterol which upon reduction of the

D 5,6 produeing
D 24,H double bond

would prGduee chol.. terol.
On the other hand, . .1dance has a1.0 been aee~lat1n,

that a lUBber of aterola with a ..aturated atde chain may have a
role in choleaterol biosJ1lth... ia.
that

D 7-cbol..ten.ol

I1U'.!£.Il., (14) bave shown

1. rapidly coavert4Ml to ebol.sterol.

N.ld.mls. . and Wall. (110) have identifled 4-

a -aechyl- D 7.

abol. . taol 1D rat tt..... and d....8erated it. corrveratoa to
cb.oluterol by isotopic _thods.
sterol iD a .yst.

(60).

!!!. nCrl

811111.- conversion of _tho-

baa been reported by hanta

.!! .Il.•

ItarKlatch . . Ilua••l (79) have 1801ated 24,2.5-dtbydro-

lano.terol, 4-

a __tbyl-D 8.cbol..tenol, 6

7.chole.tenol, and

7-deb.ydrochol. .terol frma a lIOUIJe t . . .r aDd obeerved labelilll of

the.a aterols DY Cl4 acetate.
The aeeODd pathway froa lanoaterol eo ehole'terol,

tb_.

lavolv.. the reduction of th. 24.25 double boDd of leosterol ..
the fuat atep produc1a& dibydroI8llO.terol. _ich then would loe.

28

the three methyl groups by the mechanism described previously,
followed by a "shift" of the 8,9 double bond to yield

6

1.

chole.tenol, which upon another "shift U of the double bond to
position S.6 would eventually produce Cholesterol.

A recent report indlcat.s that the latter a.chant.. ia
probably the major one occurrins in phY'iological syat....
Schroepfer (129) has found that sterols with

6

24 double bond

are not 81plflcant intermediates in the conversion of lano-

aterol to chole.terol.

Z,...t81.'lOl (~ 1 ...choleateool) ... found

to be more r ..dily convertible to cholesterol than ... zymo.terol.
Th. cbrOlUtogr_ of the sterola obtained ft'OlB the boIIo.enata

incubated with .,.,atenol waa

aua..tive

of the pr••ence of thr. .

radioactive c08lpC)UlUla IIOre polar cbroaatographlcally than

cholesterol.

One of the.e compound. va. t8Eltatively ideatified

•• 7-dehydrocholesterol (cbol_ta-'. 7-41_-3-

(3 -01)

on the b ..i .

of the cftrcaatosrapbic behavior.

laDdutch (78) bas found that rat liver homogenatea
readily convert 7-dehydrocholesterol into cholesterol with NADPH
•• a cofactor.
of the

D 7·bond

It would . . . . therefor.. that the final "shift"

involv.. the formation of •

6::. S bond

first

followed by a reduction of the ~ 7 bond to produce chol••terol.
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TABLE 2
TilE BIOSYNTHE..SIS OF C:1roJ..~;TEROL

l'RANSPORNA.TION OF LANOSTET:;')L TO CHOT...ESTEROL

1..ANOSTEROL

,

4, 4-n1methylcholeata-8 t 24-dien-3-p-ol

1

1
Zyaoaterol (Cboleata-8.24-df.e.nol)

1

1
1

4-B-Methyl-As-eholestenol

1

Desmo.sterol

1

1

A7 -Cholestenol

1
7-DehydroCholesterol

)

OliOl£STBROL
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The fiDal tl"aasfOl'llatiou of 1__ tarol to ebol..terol ara

.unBlr!'" in Table 2.
Cbol..t . .l

acetate.

i..

therefore, _t1rel,. 8yatbeaiaed fre.

ly ....t ......8 to be _

in'ever.1bl. reductioD of

IIMG-CoA. ill aotive *I'Ii11briu. with acetate, ..,aloDie ac1d Is

fomed _ida 1a tb_ COIlYerted iDto 18opeat-.,.1 pyropbo.pIlat.

bavirla 'both aucl_pb11ic ... e1eeaopb1110 activity. Utili.illa
bocb of th... actlv1tl.. they live ri•• to beeN.dtat_

<pr.,.l ad fara. .,,1 pyrophoapbatu) It, a had to tail
pol,...1uC1on.

larue"l pyrophosphate tb_ 1. . . . . Jolaed

tail to tail to prod.ac. . . . .1...

Scpaa1. .e retda. 11UOleopb.ilie

activit", 07cl1.181 1:0 l.o81:e1."01, wid.• .".tuall,.. .,,. a ..r1.s
of reacti__ , produc.. chol..tero1.

CHA.lTD. II

TIll IIOCHDlISftYOr HYJIOOLYCIHlC

COMPOUJU)S

HISTORY
Dlabet.. .a11itua , . . . . . . .lo . .~11o 41aorc1e1'

charact.r..... "7 • di.t_baH 01 lipid ... cU'Mb,cb:ate ..cabo11_ ad . .Uut_ b, .......... toler. . . to c.......yclr.t••
!he oonclltloa • .,.lops either _ _ the pre4uctloft of iIlauliD is
1DacIeqaat. . . . _ _ tile dCl_ . f laaulla . . the ti.....

u

anta.-tud.
MaDy f_t, led to the Nlul tbat CIae pa1ICI'''' pro-

duced a boraeae _lch . . . .ec....,. for dte . . .1 _talteliaa

of oa:noh,cIr....

I. I ••' ,

that the r_09a1 of the

VOD

Merta ... 111_. .i (102) . . . . .

,"'1'''' caHd d1al:tete. _111cua.

, • •ad likel, that til. duetl... lalees of

~

source . f • •eerecion, . . . . . . . . . c _ _ the
De

He,. (lOS)

iD 1909

,_.ted the _ _

It

.... the

',..G••'.

"",&It

for eM

hypetlletiw iDt....1 leeretloa of the . .erqa.

It ... DOt atl1 1922 thae "tina aM ...t (7) (I) (9)

succeed.. ill atractiRI a pr....at1oD I .........1 .,........ coat.1II1.. tile _tUiabetle u r _ iD • fon 1IIlicll coa....tatly
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alleviated all manif•• tations of diabetes in totally depancre.thed do,s.
Ever 8inee the isolation of taeu1to, a ••arch for or.l
hypoalyeemtc compounds ha. been 1n effect.

In 1926, Frank,

Nothaan. and Waper (57) reported the hypOllyc_ic effect of a

d1guanide, synthalin.

Grah. and Linder (65) etudied this

coa&potJ.nd and found that it caused severe liver d_,e. and it

waS soon abandoned as a hypoglycemic compound.
Plant extract. have been us.d for a lonl tilDe as
reMdi•• for diabetes mellitus in many parte of the world.

For

ex_pie, Allen (2) investigated blueberry leaf extracts and

Hush-Jon.. (73) studied the extracts of perlw1Dkle, mistletoe,
and nlckerberry.

properties.

Many other plants po.s.s marked hypoglyc_lc

The two alkaloid.. ,alepine (108), from the seeds of

GAIH' 2fflcina11a, aDd lapartine, from the seed. of L!Pipu! albus.
have the property of reduclns blood eUler of nonul individual.
and diabetics.

Other materials with hypoglycemic properties have

been extracted from a wide variety of plant tis.ue. and bacteria
(37) (89).

Ha.sall. Reyle, and Feng (68) teol.ted • hypoglycemic
compound froID the unripe ".ckee... the fruit of a plant t 11iM!.
•

'!hie c

"ieh

called Hypoa1ycin A.

Anderson.!S..i!., (4) and Ell1ngton, Haasall,

and P11uaer (48) detm.-mined that the hypoglye_ic activity . .a
due to an amino acid, whose structure 18 given in Table 4.

A

second hypo,lycem1c compound has alao been isolated from the . . .
plant and the name Hypoglycin B was given to it (68).

It is a

polypeptide composed of HypoglyciD A and alutamic acid.
A

DeW

era of hypoilycem1c oral compounda

b.aan

1n 1942

when JaD1itoD, Chaptal, Vadel, and Schaap (75) discovered tbat
S-l.opropyl-2-sulfanilamide-l,3,4-thiad1azole (a180 called

poa ....ed hypoalyc.ue properties.

IPTD)

Fillally, Franke, Achelu,

Betra .IS. .fl., (1) (13) (58) found that l-butyl-3... aulfooylurea
(alao called by its seneric name carbutamide) had a hypoilycem1c
capab~11ty.

Since then. many hundreds of cb_1cally related

compounds have been atudied for their hypo,lycaaic activity
(30) (98).

the majority of theae C08IpOUDda and preparatlona vere

found to be too tOld.c for luJID8D use, but three analo,_ of
carbutamide. namely tolbutmaide, chlorpropa:J.4e, and metah_ _ jde

have .,.. subjected to clinical .tud:l.•• , and two of

th.,

tolbutamide and chlorpro,.14e, are be18& ext.alvely uaed for
the treatMnt of 11114, adult, diabet.. M1lieua.

'l'he third,

..calla_We, ...

v1tbclr__ fre. the . .rue bee. .e ie did DOt

off_ . , iJIportant n.w litenefic1al futur...
DlSOLD

AJU)

THE AltYLSULJ'ORYLUltIAS

a.

replac-.t of the

,...iAo

JI'OUP of carbut_ide

wldel, uaecl :1a diaMte. therap,. tollMataa1de (R-butyl-II'-ptolu_lfOD,lurea, .... tiaoft. OriIIae, D 860. or U 2043).
chaD. . of tile . . .tltated arouP _

1'he

the MDa.e rSaa 11 re.poa-

.:1bl. for __, lIIport_t "101oateal differ_ce••
III __ • tolbute1c1e t. converted lI'1to freely 801ubl••
DOG-toxic. carboxylic acid (II-bat"l-.' -p-carboxypb_,laulf0ll1l-

urea) b" oxlclaticm of the , __thyl •••citu_e (90).

.-but,l-II'-

p-h,..."..,llulfOl1,lur. . baa ala. .... fOUDd iD blood I.a very
_11 .....t..

riaally, Mobn1ke _d Wltt. . . ._

(105) i801ated

fr_ the ur1u of cI.p a toxic ..c&bol1te of tolbutam.e.

p-eolu_lfODaide and .ocher cOIIpOUl'ld 1Ihic:h .... . . . later
to be ,-tolueDMUlfoo11urea (106).
aid. 1a doH by the kieJae,.•• _101,

'lbe el1aiDation of tolbuta-

a.

the carboxylic acid (55).

TolbucaRide a. ccmtraeted with carbut-'cIe. doea Mt .1p1f:l-

.l......

cantl, affect thyroid funetlO1l .. ......eeI b, 1131 .twlt...
(101) •

The

t of the lO:lter procluciDa propert:l.. of

35

the arylaulf_ylur... coaea from th. removal of the

,-_lao

group (97).
Ollorprop.-1cl. (If-propyl-N' -,.cblorobeueDe au.lf0l.\11urea, O1aben•••• P 607) cllff... fr_ tolbutam.de 1ft the fact that
the ,....cbyl &rOUP of tol1Mac.lcle i. replaced b1 a chl.iDe at_
aDd the alkyl radical, but_. la replaced by propane.

1D_.

thi. eo.pouad, lD COIltr. .t with tol'*t. . . . . la probably DOt
aataollud before . .er.tloD.

. . clef:Lnlte cbr_toaraphlc or

ultraviolet _aorptioft diff_.c.. hav• ..,.. fouad beh'MD the

pur. cb:u& aacI tbat b • . , .

OJ."

viDe (76) (138).

V.iq tbe uriDe

of clop treated with cblorprop_icle-S3S • however, thr. . diff_at
c~top:apblc

.pot. were ct_actad.

!hey .... lel_tlfled .. th.

UDCbapd eo.pouad, p-dllorob_ _ ulfoaylurea. _

and 20 per c_t reapective1y.

p-cbloro-

'l'bJNld fuDctiOll a . . . . . . .ad hy

, 1 _ prot.lD-houDd iocIiDe level. and tbe thyro1cl upCak. of
radioactiv. iodiD. 1. DOt iJlpUreci by chlorprop. .de (135).
~ab....lct.

(.-oyoleb..,l-.· ... ('.I8da0-4-toluea.aulfo-

Dyl)urea. ,,17Cb) 1. a VflrI effective bYPOl1yeeeic eo.pouad
with a duration of action whlch 18 lonpr thaD tbat of

chl0rpr0paaide.

It 1. Pout balf . . .ffectlv. . . ehlorpropalcl.
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Carbutamide

Tolbutamide

Chlorpropamide

H~C

-

« »-

S02NHCONH -

I

NH2

0
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and about five times as effective as tolbutamide in producing
sustained blood levels (82).

Dogs and rabbits excrete 30 to 35

per cent of the administered metabuamide dose unchanged in the
urine and 40 to 50 per cent as 3-amino-4-benzenesulfonamide
(l25a).

Since it was found the metabaxaaide caused obstructive

jaundice (56) (96), the compound has been withdrawn from
clinical studies.
Insulin is a polypeptide which, when taken orally, is
rapidly destroyed by enzymatic action in the gaatro-int.stinal
tract.

Althouab attempts have been made to protect the insulin

from being diguted, preparations livinS adequate absorption when
administered by aouth hcve been unsucces.ful.

Daily injections

are needed for patients with diabetes mellitua in order to
maintain load health.

Since it haa been found that the action

of insulin is influenced by the size of the crystals (151),
different preparatioDs have been made utilizinl zinc suspensions,
protamine suspensions, amorphous zinc insulin, and different
combinations of the above.

By

usin& different ratios of these

preparations, altaost any desired duration and potency can be
attained.
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~x;rRAPANCREA'rIC

EFFECTS Of

The mechanism by

TH~ ,H.l{YWULFON~LUR£AS

~ich

tolbutamide and other hypo-

g11c-.10 aryl.ulfonyluraaa exert their hypoalycaaic
atlll riiapu.tad.

actio~

1&

It 111 PDerally aaread that in ..... la the

aryl.ulfOllylurua produce bypoglycaaia only when
pancreatic bate-celle are pre.ant •

a01Be

funct10niDa

Houa ••y ami Penhoa ( 7 2) at., -_

that the pr. .ence of . . . pancreatic ti••ue 18 ...ential for the
bypoalyc.u.c effect of the aryl.ulfonylur....

The arylau.lfayl-

ureaa reduca the iaatina blood au,aar level of intact and

partially pancreatectomized or mildly alloxan diabetic anima18,
but they do not do

80

after total pancreatectomy 111 daP. rabbit••

rata, or un (104) (149). nor 111 miaal8 IUd• •everely diabetic
with allOUD.
AltbQU&h the avid_c. indicat. . that their adm1niatra-

tion reault. 10 deer..... iDaultn tn tha pancr. .tic vein (113)

(120). __,. . .tabol!c effecta which accoaapaDY arylaulfonylure.
1nchtcecl hypoalyc..u are eo differant fro. thoa. which accOIIPatl,
iDaulin :lDduced hYPGllyc.u.a that a. . iaveatiaatore poatulata

tbe preaenc. of . .jor eatr.p&Dcreatic factora of ary18u.lfoDylurea
act1oa.
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rat liver sllc •• , have been found to decrease epinephrine-induced
glycogenolysis (l43c) and ketogenesis (24).

When rat liver

homoaenates vere used J tolbut..tde was fOUl'ld to alter the
activity of a number of enz,..., including at least one

trans..maa. (23), aeveral NAD aad MADP requiring ayst... (147) J
and the phosphoryl..e reaetlvat:iua ayet. (11).

To1butaa1de and chlorpropamide administered Ja ylvo
deer..."
tered

ketos_•• ia (24) (27) (SO) (124).

!a nyo,

~itro.

To1butamde ad111nls-

with the .ffeet _.surad 81ther

in vivo

or

!n

has Mat found <a> to decr.... .1uco.. output (l28a).

(1:») t.o 1Dereaa. the 8yneh.sla of 11ye_, facty ac1cla, aad

protaia, without the eorr..poad1aa atrabepatic .ffects .een
with 1uullD (123). (e) to deer.... th. coavars1ota of fructos.

8IlCI plactoae to a1. . . . (122). . . (eI) to altar the activity of
~

_,...a,

1acluc:liDI iDcn:eaaed activity of . .lie . .,..

(146) (147).
Cblorprep..tda . .y, UDder eart.ira coadltiou, sliebely

1ncr.... tbe 11yeo. . coat_t of rat diapbrap, _11. UDder
.t.11ar coaditl00e tolbut..td. baa DO aff.cts (35).

,..1de al&. aodaratel,

Cblorpro-

.apr..... 81ut..to-oxalac.tlc tr.....ta...

aetivicy ia tba liver. of wl1 fad atdu1& (128).

THE GUANIDINE DERIVATIVES
In 1926, Frank, Hothman. and Wagner (57) ayntheslHC1

Synthalln A (decamethenediguanlde) after earlier reports .tated

that the administration of guanidine lowers the blood sugar

concentration (148).

A f_ diabetic patients were treated with

SynChal1n A, but it was subsequently proven to be quite toxic
ev_ ill ...11 dos.. (12), produein& hi.tololical chan... 10 the

liver and kldney and all cl1oi.cal ua8 of the ccapound was
diacoat1Dued •
In 1957. the bypoglyc.u.c effect of phenethylb1guanida

(N'-beta-pbenethylformamid1oyltainourea hydrochlorlde, DII,
fbeafonain, Dibotin)
Freedman (130).

w..

described by Schapiro, Parrino and

They ioYa.tipted approx1aately two hundred

aono- aDd di- substituted alkyl and aromatic derivatives of
foaaadiny11la1nouraas, and found the pheaethylbipalde w.. a

hi8bly active oral bypollyce.ic eo.pouad in both Dor.al end
alloxan-diab8tic animal••
Th. Mda of actiott of ph.ethylh1panide 18 different
ira. that of tha arylaulfonylurea. a. the compound produce.
hypo&lyc.na in pancreatectOlBiaed animals (109), in severa

alloxan diabetes (143.). and in patient. with Juv_lle or
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TABLE ...
GUANIDDlE AND 0'J.'HE1l HYPOGl.ycmac COMPOUNDS

H~ ... ~ ... NH2

Guanidine

mt
H_N ... 0 ... NH (aH ) NIl ... 0 ... NR2
2 n.
T'
n
tt

Nil

O
~

~

Nil

H

#

"

N

... (CR )",N'R - C ... NH - C ...
2 "n
"t

at2 c,'" /0 .. CR2 CHC02 -

Ha

Synthalin A (u=10)
Su'ftthalin.
8 (n=12)
., ..

NH

NH

Pbenethylbtgwmide

It

Hypoglycin A
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insulin-deficient type of diabetes (114).

Ph enethylb iguanide

increases the glucose uptake by the rat diaphrap

the musele Ilycog80 content decre.ses (152).

!!l vitro, whi1.

A marked increase

in lactic acid production and a decrease in oxygen consumption
su..ggeat that phenethylbiguallide stilllulatea anaerobic glycolysis
by inhibiting oxidative enzyme .yst....

Wick, Larson, aDd Serif (1.50), uSing adipose tissue,
have .bawD that phenethy1b1guanide inhibits the oxidation of
,lucoae, acetate and .uccinate and coD8lclerably reduces fat
synth. .18.

In man, the blood pyruvate and lactate levels are

raised ('1) and there 1.

DO

pyruvate or lactate,

in the oxygen conaUIIPtlon of the liver

(143.) •

DOt:

chana. 1n hepatic vein gluco.e, urea,

Lactate lavale 10 the blood from the £..ora1 artery

also r_in UIldlanpci.

Hypo"lye_a cannot b. produced in normal

humans by the adatnistratioa of pbeaetbylbiguanide (51), althoulb
with iatact _illa1a • deer.... in the blood sugar concentratlon
la ...11y produced.

Thea. reaults auaaest that the effeets of

pheaetbyU,ipanide are lar,al, mediated in the peripheral

ti.sues.
Tha tissue anoxia sugeated by this avid_c• •, be
attributed to inhibition of cytochrome oxida.e and succluic

F
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dehydrogenase (137) (143b). but a decrease in oxidative phosphorylation would have the same result.

Later work suggests

that biguanldes inhibit the transfer of enerlY rich phosphate
bonda to adenosine diphosphate (50) (31) (121).
Phenethy1biauanide haa also been found to s ignificant1y increase the levels of s.ru. inoraanic phosphate (132)
1IIb. . . . the arylaulfony1ureaa decrease the serum inorsanic

phosphate (74) (138).

Williams

~~.,

(152) found that

phenethylbiauaDWe inhibited phosphoryl... phosphat.s.. the
ana,.. catalys1na the conversion of phosphorylase a to pbospbot:y1... b.

They al.o fOUDd that the compound had no effect

on the activity of phosphoryl... a or phosphoryla.. b or on tb.
enzyme depbosphophospboryl... kinde which catalyzes the con-

version of phosphoryl.s. b to pho.phoryl..e a.

An inhibition

of phosphoryla.. phosphat... in vitro would favor an incr....
in the amouat of pboaphoryl.s. a pruent in the ti••ue.

Since

phosphoryla.e a 18 believed to be the form of the . ., . active
in ,lycOlerlolysi., tbu could account for part of the d.er....
in Ilyco. . produced by pheutbylblauanic:le.

RYPOCLtCBNlC COMJIOUllDS AID STDOL MBTAIOLUH

Altbou.ah .tud1.. _

til. lac tea

y.....

th• •ffec' of

01117 r __cl, baY.

.y

ca.

hYPOllyca.1c

report. a"..racl

01\

tbe .ffect .f th. . . c ........ OIl crhol. .terol MtaboU..
SId.pp -.4 MUaroe (131).

clurtaa the

,..t year, .....

fouad that t.l...... t_1. . aultatalltial1y deena.eeI blood .ol..t.rol
1Il bypereholMtero1e.1c ... hyparalyceaic patieDt..

Ira

tile blood CODc_traCioIl of cIaoleacerol ... al_ aoucl (29) (13)
(66).

o.a (112) ...,.hd tbe .ffecc. of tollMa'. . . . . _1erpro-

, . .... ad ac.coha_lda
aacl fr. . fatt, ac14..

OD

tIM blood . .l . .tRol, COtal 11,1c:1a,

!be ata iIld1eaUl tbat all tIar. .

&1')'18,,11_,1..... that . . . .

".eeI 1B the tav..tiaatiaa

tbe chol..t ...l 1...1. of tbe patiat..

lowered

riDa11,. Lrbert (8S)

hal reported tIlat pheutbyl1d.paa14. reclucecl tU total ...1..-

cero1 l ....la of the blood ill 15 ouc of 30

d~le

,.eiat••

Til. 'uppz'. . .i_ of daol. . terol bio.yDtla. .1a by tile

b".a1ye..t.c • •, ouacl.

1I1aht partial1, ..,laiD

til. 10wftiq of

bloocl . .l . .cu.1 ob. . .eeI after the ada1a1..trat1_ of eb.

b".,1,. . .0 cOllPOUJlCl..

Una.l1 . .

.I1.,

(11) aot. . . . 1acr_ _

p
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incorporation oJ: mevalonate-C 14 iDto cholesterol in poorly
controlled diabetes and ketoacidosis, while Hennes and ReddLQa
(70) reported tbat the incorporation of acetate-l-C14 into
~~olesterol

in diabetics is decreased after administration of

chlorpropamide.
Reduced lipogenesiG and incr...ed lipolysis are
recoaniaed features of tne diabetic state.

the increased fat

mobilization resulting from a deficient insulin effect

OD

adipo.e

tissue can account for the increased blood concentration of free
fatty acids.

'l'be mechanism for the incr.... of cholesterol in

the diabetic 18 less clear.

Siperstein (134) ltas suggested. that

excessive quantities of acetate and acetoacetate derived from
lipolysis are diverted toto ketone bodi.s and cholesterol
synthesis.

Altnougb acetate and acetoacetate

mi&bt be diverted

into ketone and cholesterol synthesis 10 diabetes mellitus, they
are not incorporated into sterol durina treatment with the
hypoglycemic compounds (10).

la vitro studies have sbown that

tolbutamide, chlorpropaadde" metabexamide, and phenethylbipanide
inhibit cholesterol blosyntheaia from acetate-l-c 14 (44) (45)
(100) (101).

Consequently. it would b. of great interest to
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Know at what step in the biosynthetic pathway of cholesterol

biosyntheais the inhibition takes place.

'£be

dissertation will.

therefore, deal w.lth otudies in the elucidatiOD of the sita of

inhibition of eOOlaatuol biosynthesis by the hYP'Oalye.uc
compound., toliNt.u.da. c::b.lorpropamide . . .tahexamide. aDci

pheaethylb1guanide.

CHAP'rD. 111
MATD.IALS ABD METHODS

'ftle . .terial. aacl . .hod. u.ed in the inveatiaatiem of
the aite of 1nb1hition of chole.terol hioayntheais by h"ollyc..tc
co.poanda are described in this chapter.
MATERIALS

Aft&l!l. - The ent.ala •• lected for ua. in the exper1I18Dt. were Sprape-llavley . . Ie rat. obtained fro. Abr.. s.all
Stock Breeder.. Chicaso. Illinois.

t'he rata. ".ipina approxi-

mat.l, 200 11'... , were kept on a replar diet.

Sacrificinl"s

done by decapitatiem.

Bxpg&lxc!!!ic CO!!pO\!ndl - Tolbutamide, aodi_ salt

(lot ICJO II, '84-2) and _tah __id. (lot #CJo 12. 860) was
aupplied by The Upjobn CoIIpaa,. Kal.a.oo. MichilaD.

Phenethyl-

b1luanide hydrochloride (lot 121) .al supplied by U. S. Vit..tn
Corporation.

a..,

York, . . . York.

Chlorpropamide (lot 103-422-

021PD) vaa supplied by Charle, Pfiau ad CcapanY. Inc., . . .

York. Ifew York.

1'be purity of th.,e hypoalyc_ic c.,ouacl,

corre'poDd, to that of analytical &rade

rea.ae,.
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gsg,... •

1l1cotm.1dta _.10. dtDueleotlde. reduced,

dl.041w1 s.lt, (lW>B, chr..aCOp'apbically pun, lot: 16501),

alcoch,_ld. __iDe d!auol_tl... phoaphat., reduced, Mdl_ .alt,
(1W)PH, cbr_COp'apblcall,

pur.,

10c 16103) aad ad.iDe td-

phoapbate. d1aodt. .alt. (Aft, lot 113'-A) .... ot.taiDed fre.
, .....t LaI:toratori... Mil...... Wiacouia.

Glut.tbioM, reduced,

(GSR, lot 164'24") . . . ObC.iDed fro. Califoni. Corpor.tloD for
I~.l

........ Lo. ",.1.. t Cal1forala.

MI!J1oBl! .c&._1_CI4 ... ""II011c .eld·a.C~

• OL·

Mev.loaie acid 1actODe-l-C14 (lot '1) ... _ta1aecl fro. lhaclearTbe 8rtp.al . , . i f

Olio.., CHpor.t1oll. DH 'lalrau, I111rlola.

activity of 3. "

fII:/fIM . . dlluted vitia _label_ DL-Mvaloaic

acid l_COM (lot 112634) _ta1Md fro. MaaD

a......eIl

Labor.torie

IDe., . . York. I I . York, to • _,.tfic activity . f 0.16 .:/• •
Th. purity .f the labeled ....laDO-1aCtoae
_faaeurer "

was ell. . . .

'y the

dilutSa aaal,._ta ... ,.,.. chroIIatop'apll, . .

fouacl to ... 9.-992. ,..••
DL-~a1oa1c

dl

acid-Z-C14 .. the •••·d~71-.tb11_.

s.a·('.' dibJ*0x7·3-Mtbyl . .

ODi.....

t . . . .t.) ••It (DIID

••It) ... oIJt.tDed & . _. Baal_d )Jucl. .r Cocper.tioa.

.....achuett..

_toR,

11l. orliSul specific act.ivit" 1.19 .c/rM., ••
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diluted to a particular level (shown in the tables of re.ults
under "Conditions") with unlabeled DIED salt of mevalonic acid
(lot ID3l05) obtained from Mann Research Laboratori...

The

specified purity by the manufacturer was 99.St as evidenced by
the radioautogr.. of the DBED .alt of DL-.... lonic acid-2-C14
given in 'isure 10.

In earlier experiment., DL-mevalonic acid 1actone-2-Cl4
(lot 115) obtained from Nuclear-Ch.icago Corporation, was uaed.
The .pecification. and dilutions were the ....
DL-mevalonic acid lacton.-l-C14 •

&8

liven for

Other chemical. - The sourc.s of other chemicals used
in the inve.tigation are stven in rabl. 24, in the Appendix.
Tis.ue hOlllOleni.er ... The rat livers were hOlllOleniaed
in a homopniaer of the Potter-Elvehj_ type which consisted of

a smooth 11... tube and stainl..s .teel peatle with & I8P of
approximately 0.5 am between the pe.tle and tube.
ME'1'RODS

lERHltlO1\ of liver MEMI.tg - Livers .... obta1a.ecf
froa rats w1ahiDa apprexiaatel, 200 p . . which were sacrificed
1t1 decapitation.

The livers were blotted t

w1Jhed, aDd arouad

._tlyat 700 r,. for one to two .iIlute. with 2.5 vol.... of

p

,
,,'
i

so

Ii

!

PIGURE 10
RADIOCHRCltATOGRAM OF MEVALONATE-2_C14

Chromatographed aa the salt of N,N'-dibenzylethylenediamine.
The developing ao1vcm.t was ethanol:NR4 0H:water (8:1:1 v/v/v).

Full scale deflection: 30,000 cpm.
Origin i. at the right; solvent front at the left.
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phosphate buffer (0.1 M. pH 7.4) (59).

Unbroken cell., ti••ue

debri., and the mitochondria were .1ia1nated by centrifuaation

at 10,000 x , for 30 minute. in • Spineo Ultraceotrlfuse
Instruaent. Inc., Sp1llco Divi.ion, Bel.moftt. C.lifornia).

entire proce•• vas carried out .t

oOe.

prepared vere useel 111 obcainilll the

.,.t_

(Ieo~

Th.

TIl. homo,__te. thus

eDa,..

nec....ry for

chole.terol bio.yatk•• i. fro. mavalonic acld.
lr!parttMi of

e.dur.. of Popjak .11

~,

.11••

the prepara.tion of th.

au• •utS • th. oOlll)in84 pro-

(118) and Popjak (184) vel"

eo.a,... nec•••

chole.terol from mevalonic acid.

u.ed lor

ary for the blo'yI\tA•• i . of

Th. 510 fra.ction pr.pared as

ahoY..... c_trifuaecl at 104,000 x I for 90 aiaute..

The Sl04

,upanlat..t va. pipetted off. c.r. lite1a.a talt_ not to di.turb

the

.ad~ted

particl•••

Th•••dla_t It wlaicb contain. Idero..... va. r.aua,.uled
in a volume of buff. . . . .1 to aboc _ . . . . .t.r of the oriaJ,aal

vol_ of the 8 10 ad ••cu._ted . .ata at 104,000 x

ainut...

a

for 90

'l1d.. tiale the .u,....tant ... di.carded and the washed

aieroac.a.

wer.

cll1at... to 0.1 voluae of the 1 10 ••punatat from

which th.y ........eparated.

The mero. . . . thu prepared were

k.pt at -15o e _til . . .d ill

ca• •par__t ••

p
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The supernatant from SlO4 was satu.rated with solid

(IDi4)ZS04 (6.3 ,/10 ml of supernatant).

oOe,

filtered off overnigbt at

The precipitate w.s

dissolved in 0.02 M KHOO 3 (12 .1/'

g of precipitate), and dialyzed for 3 hours against 0.0% M KROO,.
The dialyzed solution was then fractionated with (NH.) 2804.

lbe

precipitate obtained fro. 0-301 .aturation ... diacarded and the
solution ... s.turated to 601 (NH4>2S04.

The precipitate obtain

after the second precipitation vas stored at -1SoC until the day
of the aper1ment, 'tIlten the precipitate was apin dissolved in

0.02 M 000, (12 al/3 I of precipitate) and dialyzed for 3 hours
qa1nat 0.02 M

moo,.

'lb. dialyzed material vas then treated

vith protadn. sulfate (2 ma/m1) and tbe precipitate that was
obtaiDed va_ discarded.

The supemataDt vas uaed ill the experi-

ment. .. • sourc. of soluble _ , . . . aDd will De referred to
"dialyzed .olu1>l.

.,.t.

eaa,....

a8

fI

lb, procedur.. uaed for the i.olation of the • •,..

are..

.riaed ill Table ,.

'A' "'Mlt!S

lIi.surl • Each iDcubatiora v •••• l ccm-

eained 1.0 IIll of dla1yud .01ub1e

._yme

(17-21 . . of proteta).

0.02 IIll of microsomes (7-11 . . of protein), 1.0 ml of substrate

solution, ad the bypoalyc_lc compound in the specified .-unt.
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TABLE 5

FRACTIONATION OF LIVER ENZYME SYSTEM.

H<J.:1OGENATE

centrifuged at 10,000 x g
for 30 min.
I

I

Sediment
mitochondria;
discarded

I

Supema~ant (S18)

centrifuged at 104, 00 x g
for 90 min.

I

I

Sediment
resWipeclecl in buffer
and centrifuged at
104,000 x g for 90 mtn.

I

I
Sediment

I

I

sur.rnatant
d scarded

'WASHED
MICROSOMBS

<contains all
the required
enzymes for
choleaterol
biosynthesis
from farneayl-PP

I

Supernatant (8 104)
+
(NH4)2S04 to 901
saturation

I

Precipitate
discarded

Filtrate
discarded

I

..fractionated
with (NH4)2S04
I

I

30-60% saturation; precipitate
dissolved in 0.02 M KHOO3 and
dialyzed; solution treated with
protamine sulfate (2 mg/ml)

I

I

Precipitate
dissolved in
0.02 M t<HC0.1
ad dialyzed

I

I

saturation; precipitate discarded
0-3~

I

Supernatant
SOLUBLE ENZYMES

(contains all
required enzymes
up to the synthesis
of famesyl pyrophosphate

The volume .... ..de up to 4 .1 with phosphate buffer.

Th•

• ub.~rate solution contained 2 .icromale. of NADH, 1 micromole of
Ddcromole. of ATP J 30 micrOllOles of GSH, 4 IDicroaaole.
of Mn++ and 1.0 adcramole. of DL mevalonate-2- or _l_C l4
NADPH, 30

(0.37-0.74 microcurie. of C14) in one ml of phosphate buffer
(0.1 M. pH 7.4) containing 16 micromol•• of M'·~ and 0.03 M nlcot
inamlde.
The protein contain.d in the microsome. and the
dialyzed soluble fraction was measured by the biuret reaction
(64). the d.scription of which i. aiven 10 the Appendix.

Incubltiggs - Studi.s on the incorporation of
mevalonate-2-C l4 into the non-saponifiable lipid were carried out
a.•robica1ly in an Elmac metabolic shaker (Elmac lmgineerins Co ••

Chicaso, Illinois) at 37°C.

The oxygen was introduc.d into the

incubation v....ls by a s.rie. of TySon tub ina sections into

each lDdivi4u.al v••••l.

In studies 10 which CO 2 was det.rmined.

the oxygeD served a dual purpose 10 that it "as also used for

fluahtna the c1402 that was produced.

The radioactive carbon

dioxide was collected in pyrex test tube. containing

solution.

lO~

IOH

After the .pacified incubation period, the reactions

wera uaually .topped by the addition of l .1 of

lS~

KOR in 504
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TABLE 6

COMPOSITION OF THE INCUBATION MIXTURE IN THE BIOSYNTHESIS

OF CHOLESTEROL PROM MEVALONATE_2_C14

1.0 ..lot' soluble enzymes precipitated between
30 and 6~ saturation with (HH4)2S04.

0.2 ml of microeomaa

COENZYMES

Substance

Conceatratl_
p.molesL4 ml

ATP

30.0

tW>H

2.0

HADPH

1.0

Glutathione, reduced

30.0

Mr\++

4.0

Mg++

16.0

(Nicotinamide)
(0.03 M)

All in 0.1 M phosphate buffer.

pH 7.4
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.thanol to each incubation v .... l followed by heatina for 10
adnut.. at 37°C.

In incubation. wh.r. only the radioactive 00 2

vas deterained. the reaction. were .topped by the addition of
0.5 .1 of concentrated sulfuric acid.
'!olltion IDd extrlction of

nOft-!!P29if~l.

lieid, ..

The partially .aponified reaction mixtures were transferred to
2S .1 screw-capped culture tub...

the react10n ves •• l. were

rin••d with 3 .1 of the a10OOol1c KOH solution and the riDSe
added to th. contents of the culture tub...

Saponification .a.

completed by heatin, tbe tl&htly capped tub.. in a water bath at

7,-aOoe

for one bour.

The saponified reaction mixture. were thaD

cooled and extracted four times with 10 .1 portiona of lilht
petrol~ ether (30-60° hollins fraction).

This solution con-

tained the total non-sapcmifiable lipid co.posed of all the
tnter.ed1a~es

of chol.sterol biosynthesi. from squalene to

chol"'erol. iDelusl.el,.
In experiments in which only tb. chole.t.rol v..

deterained, the petrol. . ether v.. evaporat.d to dryn.ss in
heavy-duty centrif",e tubes.

The re.idue "as dissolved in 3 101

of acetone-ethanol solution (1:1 v/v), and 1.0 . . of carrier
cho1.. terol :I.D

o. S

al of ethanol was added.

The 3-beta-bydroxy
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atero1. were precipitated by the add1t1oD of 7 .1 of 0.'1
dilit_in in SOl ethanol.

After atandiDa at rOOlll teperature for

16 hour.. the dilitonide precipitate ... recovered by eentrifuII

aatlOft. ...hed once with 901 ethanol, OI'lCe wlth acetone. O'OC.
with acetone-.thar (1:2 v/v). _d fiDally with petrol. . ether.

In experiment. in _1ell Nth the choleataro1 ad total

:
I

"

DOD-

.aponifiable l1p1d were deter.tDed, ooly a aultable aliquot of
the petrol.... ether extraot va.....ed for eboluterol detera1na-

tiona
l,oA.t1op of the "",enol fr.etlga - !be isolation of

the 1aoprenol.. pre-.qua1.e branched oba:l.a a10oho1 int..-diate.
of ob.e1..terol. was done by the _cbocl of Popjak (116).
.apora:lfiab1e lipid fract10D

1'be

DOD-

v.. partitioned iDto petrol_ ether

froll the alka11ne 1Dc:ubatiora a1xtuJ:e aftar .aponification with

mB.

The

a~ 1'. .1. .

_ . th.acidifled to pH 1.0 with

HalO4. After the .olution had .tood at roo. t..,.-ature for eme

hour. the pH . . . readjusted to 10.0 - 12.0 with lOR _41 th.

lsoprenol-c14 s.stac.. were extracted four t .... with petrol. .
ether aDd the activity cteterm1Decl iD a .cintillation counCeI'.
ldtBSilicatlop 01

ChI

i.oprepol_C14 .ub!~!pc.. - Thi.

vas don. by rever•• phas. paper cbr. .top'aphy of the 3.S-d1DltrobeDsoyl dariv.tlv.. of the alcohol..

The darivatives .... 1IICIe
I

Ii
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TABLE

7

ISOLATION OF CHOLESTEROL IN''tEIMEDIA'l'ES

INCUBATION MIXTURE

aaponified

(15~

ale. KOH), 2 hr••
at 75°C.

I
Extract with pet. ether

I
Petroleum. ether extract

Chromatography on alumina

I

I'
Pet. ether
eluate

SQUALENE

Aqueoua pha••

(iaoprenol-PP and other cpds)
acidified to pH 1.0
with H2SO4

and kept at room t&mpel"ature
for 6 hours. made alkaline
with KOH to pH 10-12
f

Diethyl ether
eluate (sterol.)

Add

O.5~

/

Precipitate
CHOLESTEROL DIGlTONIDE

Idigitonin

Extract with pet. ether

(
Pet. ether
extract
PRENOLS FR(Jvf

ALLYL

PYROPHOSPHATES

II
:il';
I'

i

S9

by the . .thocS of Cherooi. ad IDtrlkf.n (33).

Th. petroleum .ther

fractious . . obta:lned above ......aporated to a vol... of on.
To thi. 1 . . of ••ranl01. fane.ol, act .ero1idol,

1I111111t...

r ••pectlve1y, 40 III of 3,'-d1n1trobelUloyl chloride (recr)'.ta111ud f r . CC14)' , .1 of taoprop,l .th.r (fr. . frOID alcohol),

ancl OD. drop of P7I'1df.ae .... ackIed and the a1xtur. ... r.fluxed
for two hour. ill a . .ter bath at 10°C.
cooled ad the CODt_C_ ...bed

'lb. tub•• were then

0I'lC. with 4 .1 of dilute .ulfuric

acid (21) to remove th. pyridin.,

0I'lC.

with lal KaOH, _d ODe.

with vater to resaov. the 3,,-d1D.itro'benao1c acid.

layer thua Obtailled .... waporated to drynes..

'lb.. ether

!be r ..1du. . . .

di... lv.d in 0.2 at of chlorofon aact 100 meroliter. ... tbeD
.treaked

OIl

lliDeral 011.

WhetMD Ro. 1 fl1ter paper iaprepated with 101.

Th. chroaat0p'- . . . . the placed In a chrOllato-

P'aphy jar aacI ecaul1ibraticm . ._ allowec1 to take plac. ov.nlpt.

wer. then developed for 12-16 hour. vith 7"

The .trlp.

acetic

acid.

scrip.

of _til_tie • ..,1.. of 1 __101, fam. .ol, . .

....lido1 .. the 3,'·d1DltrobelUloat. . (prepared . . &boY.) vera
dweloped by th. . . . procedur. . .war the oOllpOU1ld. were
lc1_tlf1ecl.

I
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After the c:hroraatoaraphy, the strips were dried.

'l"he

non-radioactive derivativ. . were stained with '1 naphtholaaine.
The JIOVeaent of the derivative• •_ revealed a. dark oranae spot ••

Th. radioactive strips ware scanned for radioactivity and the
compounds Identified by comparison to the sov..ant of the
authentic samples of the alcohol..

Fiaure 11 sbowa the movement

of the authentic sampl.s of the alcohols in the ayst.. used.
Geran101-3,'-d1nitrobenaoate save an Rf value of 0.64, 1dt11e

farn..ol and nerolidol-3,S-d1nitrobenaoat. . had ideatical

af

values (0.32).
Xaolltis of .gualg - Tbis .as done by the method of
Lanaclon and Bloch (86) by cbrcaatoarapby of the non-saponifiable

lipid fraction on alumina colUIIDa 6cm high and one em in d1a8eter.
Squalene ... eluted with 100 .1 of petroleum ether after which
chol•• terol ".. eluted with SO .1 of diethyl ether _ !he squalene
fraction waa then evaporated to 10 .1 and one .1 of this solution
.as put directly into 10 .1 of scintillation solution aad counted

in a scintillation CGUllt_.
in a .1af.1ar -,-

t'be cholesterol fraction vas treated

Part of the fraction . . . further character1Hcl

by precipitation with d1ptonill aDd determf.aat1on of the

cboleaterol-d1l1tonide in a ... flow counter.

--61

2

3

4

• •
•
1IGURE 11
CHR<»IATOGRAPHY OF IS OPRENOL-3, 5 ...DINITR.OBENZOATES

Reverse phase chromatography on Wha.tmcm. No.1 paper impregaated
with lot. medium nd.neI"al oil. The developiag solvent was 7ft
acetic acid. 1 - geraniol (RE _- 0.64); 2 - farneaol (Rf • 0.32);
3 - nerol:l.clol (I. • 0.34); aM 4 - .ixture of germyl, fames,.l.
and nerolidyl-3.t.d.initrobenzoates. The origin is at the top; the
solvent front at ~. bottom. Developing time: 12 hours.
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~asur!!,nt

of radloactiv1tx - The radioactivity in

the non-saponifiable lipid, isoprenol., squalene, and in some
cas •• cholesterol, was determined with a Trl-Carb Liquid

Scintillation Spectrometer (Packard Instrument Co., Inc •• La
Granl•• Illinois) with the photomultiplier tube voltage set at

1020 v and a discriminator setting of 10-100 v.

The ccapolition

of the liquid scintillator which met the criteria of the hiSheet
counting efficiency was described by Bray (42) and consisted of
60 P

of naphthalene (recryata11iaed frOID alcohol, lot INX S)

obtained from Mathe8OD. Coleman. and Bell Co •• Eaat Ruth.ford,
Nw Jer.ey; 4 II' of toluen.-2,S-diphenyloxaaole (PPO. lot 121002)

and 0.2 .. of 1,4-dl-2-(S-phenyloxaaoyl)-benaene (POPOP,
Scintillation Grade, lot 12023) obtained from the Packard
Instrument Co., Inc., La Granse. Illinois; 100 al of absolute
methanol and 20 ml of ethylene alycol dissolved in p-dioxane
(Spectroqua1ity Reqent, lot

'OX 2095)

obtained frOli Math•• on.

Col_ _ • and Bell Co. t to . . . one liter.

T_ ld.lllllter. of

thi. .cintlll.tloD solution was added to a COUfttiq vial coatainiDl one ailllilter of the active petroleua ether solution
that was to be detel'1lliDed.
Radioactlvlti.. of solid s.-pl.. (BaC03 and d1l1toalde.)
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Reproduced from: Da1idowicz, J.E., Thesis, Loyola
University, Pebruary, 1962,
p. 76.

6S

were determined with a Tracer1ab gaa-flow a ••embly consisting of
a FD-l ga.-flow counter

(MOno-~~l-Resin

Window); a SC-83 scaler.

a Se-100 multi-matie sample changer; and a SC-5E timer (Traeerlab
Inc., W.lth_. Ma.sachusetts).

Self-.bsorption correction. vere

mad. on all solid • ..,1.. froa the ••1f-absorption curves for
BaC 140

3

and cbo1.. tero1-C14.digitonide Jiven 10 Fiaure. 12 and

13, respectively.

In both acintillation and ps flow count1D&,

a sufficient DUBber of count. vas taken to reduce the atatistic.l
error of countin& to l ..s than
1.'be

.CaDIl1n&

s~.

of r.diocbrOllatoar_ • • clone by the

SC-S' Cbromatosram Scanner .ttached to • tr.eerlab Preci.lon
R.t_ter (Tr.eerl.b IDe., Waltha, M. . . .chu••tt.) and recorded
on a Rectilinear Recordl.. Mi11i_tCir (Texaa tnatruaanta Inc.,

Houston, Texas).

THE SID OF THE IN VITRO INHIBITION OF CHOLES'l"EROL
BlOSl1l1'HESIS BY HYPOGLYC.DllC COMPOtnmS
It bal been reported that pbenethylbiauanide, tolbutaiii• • _tabu_id., and chlorpropamide inhibit chole.terol

biosynthesia fro. acetate-l-C l4 (43) (44) (45) (100) in liver
~pnat.s

prepared by the method of Bucher (59).

lbe results

1ndlcated that the max:laum inhibition with any particular
bJPOalyc_lc COIIpOUlld was obtained what the concentration of the

inhibitor wu 4 x 10. 3 M.

'lb. 1nh1bitlon of the total non-

aaponifiable lipid, however. was not the .... for each hypo..

,lyc.u.c compound.

Phenethylblguanide, aa compared to the three

aryl.ulfODylur.... decr....d the incorporation of l&cetat.... l .. C14
into the non-aaponif1.ahle lipid to a much areater extellt.

The

inhibition was approxiDlately twice as -.u:h . . that obtail."led with
either tolbuta.1d., uaetahuamide. or chlorpropamide.

Thi. was

the first indication that phenethylblguanlde had an effect on
choleatuol biosyntheaia quite different from that of the
.ryl~lfonylur....

When the :i.ncubation mixture., after saponification aDd

extraction of the non-saponifiable lipid. were acidified with
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H~4

ad the readJueteci the pH 10.0 with lCDH, thera ... _

iller.... 1a the oaltral-C14 labeled ....taDc.. ill a1xtur.. eontaiaiDI tU hypo.17c.te cwllpOUDCla.

Ttl. 100r.... 111 the bacor-

,oration of acetate-l-C14 lato the aeutra1 cOllpOUDda was the
. . . for ph.-thylbS..,.ld. . . . for the aryl.1,l1f_ylur_.

S1ace _.at. . . . . . . . . . the precureor of eltol..tarol,

tha nature of thea.

e..,....

could DOt 'be . .cartatud.

t ....l iDt....dl.t... the fonatloD

Alt1uN&h

of other Ca.pouacll 18 poe.lbla.

It ... decided t ther.for.. to . . . ..,,&1_10 acid, a .ora direct
precurlor .f cbol.. terol tIuID 18 .etaee (54) (141) (153) (1S4).
iD the elucldatioll of tile alte of lahlbltloa of chole.c. . .l

b1081fttba18 b,. the h"..ly.....c oOllpoua4a •
....lODia acld ia net oal1 a .... direct. precurlOl' of

abol. .ter.l, but alao a cOllpeuacl 1Ih1oh II DOt lavolvecl 1a a,.

other -Jor _e&holic pattnrq.
t . . . .t1D&

!hI. face leacla

...aaiflcati_. llweatipt. .a

to

_re 1a-

ia th. fial. of abol.l-

tarol bio.,.chel18 have fOUl'lCl that the radioactiv. CGIIpOUIlda
fomad iD 11ver . . . . . . .t . . or . . , . .
C14

a,le_

f r . MYal_c.-2-

are lat__ dlat. . exc1ualv.ll' &I_lated witb cbo1eatenl.

!hil _ _ I that

when th. total ....- • .,..II1&bl. l1pid 18
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detU'IIiDeci. the radloactivlty 18 due to chole.terol 1atermedlat. .
fro. .qual.ae to chole.terol inclustve and is devold of an, other
radloactlve CCBpOU1lda.

Asaln, _ . the aeutral compouads . e

Isolated. the 0111, on.. that COIltaiD any radloactivlt, are
dimethylall,l alcOhol, .e....lol. and fame.ol, all

1ot~dlat..

of chol..terol.
'l'be us. of ...,alOllie acid alleviat.. the baurds that

would be iDeurreci lf acetate . . uaed, e.l*=lall,. v:l.tb whol.
liver

~a-t...

Ia fact. the . .j07: fate of acetate ia otber

tbaD lts iDoftpo..at1oa :Lneo choleatero1.

I

Altbouah lt vas stated tbat ....lonlc acid ..... DOt

eocu . ,

otber major . .tallo11o pathway buid. . ob01..t8l'01

bioaynth..is. It ia metahollHd to other c..,OUDCIa _t direotl,
iavolved la t:U bto.yntbuis of cb.ol..cerol.
baa bMD obta1Mcl by

~l.topIae

R.ec_tly. _idale.

ed PopJak. (34) that 1a the liver

...,.. 8,.ac_ that 18 to be used in thi. tnveat.laation • .ev.lemat
ia • precuraor DOt OIll,. of squalae IIIlCI chol.. t.erol but al.o of

certain plWlO1c acids.
~let.11

!bese acida are fol'MCl Ity a ••cbani.

dlffer.t fro. that of 8,.tb. .ia of norul fatt, aclda.

It coa.aiat. of the dephoaphor,lation of all,l pynpboapbat...

I,

,I

(1ot. . . .1&t.. 10 claol..t ..ol Id.os,.th••18) aad aub. . ._t

.1

I!.. '

p
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debydroaenatlon of the re.ult1na prenol. by liver alcohol de·
hydroa.". aDd aldehyde deh7dro,enaae iDto the corr..pondina

acids.

the relationshlp of th..e compound. to the other metabolic

pathway. and the function of th... acld. in metabollsm 11 .till
unkDown.

1!hia fate of . . . .lonic .cid. however. :La couid.-eeI to

be a aiDOr one ••lthou.a,b ,rob_l,. aot .. UIliIIport.aDt on••

Th. fOl'Mtion of til... cOIIpOUDd. fra. .v.lonic acid

doe. not lead to erroneoul interpretatlon of the d.ta obta1nad
with .valOl1io acid.

The laolatioa of the 1Io,r8l101c .clds

involv. . extraction from

ell

.cidic .-d1ura.

SiDe. the ilolation

of the 1Dt.....iat. . of ohol. .terol involv.. auractiou from
Mdia other thaD acldic. tbe lIopraoic acidl have
the radioactivity of chol. .tarol 1DterMdiat...

1\0

effect

OIl

Meval_io .cld.

tb.ea» i. ...11 suited for tha Icudi.. OD the lit. of iDb1b1tlon

of chola.t.-ol blolynth. .ia 'by the hJPOllyce1c compound_.
~Icr

C

or HDOGLYCIMIC 00MP0UlU)S OR TI1I DCOUOMTIOR OF MVA-2Ilft'O TBI BON-SAPONIPlABLE LIPIDS

Table 8 ebowI that

tolbu~cleJ

in CODceatr.tiona Imown

to inhibit the 1DcorporatioD of acetate-l-C14 iDto cholesterol.

a1ao 1nbibita the fo~t1oa of chol.lterol froa mevalonate-2-C 14 •
The 1Dhibit1on i . proportional to the CODc_trat1on of tolbuta-

it

"

jii>

70
TABl.E 8
EFFECT OF TOLBUTAMIDE ON OHOLES'fEROL BIOSYNTHESIS

FROM MEVALONATE_2_C14

Conditions: Each flask contained 1.0 ml of dialyzed soluble
enzymes (i7.5 mg of protein); 0.2 ml of microsomal preparatiOl'l

(10.2 mg of protein); NADH (2 pmoles)j NADPH (1 ~1e); ATP

(30 iJ.1IlO1aa); reduced glutathione (30 (.&IIOles); MgC12 (16

~1es);

HnS04 (4 iJID01es); and mevalonic acid ( 0.5 &J.lU01e, 0.25 1J.C of
0-14). Aerobic 1acubationa at 37 C for two hours.

Cone. of Tolbu.bltide

M x 103

Cboleatvol
df.gltcm1de
cpa/tag

" Inhibition

1

NONE

3.040

0.5

2,445

19.6

1.5

1,438

52.7

3.0

816

73.2

4.0

553

81.8

S.O

461

84.8

6.0

I

85.0
i
:1

F

11
add. and attaina a maxi. . (SOl) what tolbut_We i. preaent ill
the incubatioD Idxtur.. in conceotrat1.ona of 4 x 10. 3 or h1&her.

Thi. is 1O-1.5t. lower tharl va. obta1rled _eo acetate-l-C14 aDd
Bucher ~a-t•• vere used.

The COIIpC'laon of the 1Dh1bitiOll

of cbo1..tarol hiosynthesia from both acetate-l-C14 and

.."aloute-2-Cl4 b1 tolkt_de 1a liv*, 1n F!pre 14.
Altbouah pb.....thylh1&u_id. 18 different frOil tolbutamele in lta atruct.. &Ilel h"o,lyc.uc action, the effect of thi.
cQlpClUDd

OIl

ch01..ten1 bioaynth..s.a from

approd. .tely the . _ .

MYel. .t ... 2_C 14

1.

raltle' 1ndlcatea that pheaethyl1d.pa-

D1de 1Dh1hlt. the 1DcorporatioD of _va1onate-2-C14 iDto cho1..•

terol.

The iabibitioD ill 0_,.81e to tolbat. .de iab1bit1on
:I.uofar .. the max1aa ... obtalDed with OODCeDtratioaa of
4 x 10. 3 K.

III re.pect to the ...,itude of the lDld.'b1ti.oD,

~. the ~.t1oD of ..,.loaate-2-C14

__ ph..chyl1:d.....U. 1. pr. .. t in the

ia hiah" (10-151.)

tn. __

mto

c:bol..t . .ol

.JDtb..iII1a&

tol'but..tde 18 ,r. . .c.

.,.t.

Tbi. ia

oa1y true __ Cbe OODc_trac1oD of the part1cular hypoalyo-.1c

c..,... reachu 4 x 10.3 M.
4

lC

III CODCeDtratiou 10nr tha

10. 3 M. both tolbut..t.cl. aDd pheaatby1blau_1de 1Db1blt

72

100

~.-

z

0

80

~

£D
:I:

z

60

_0-

~. o~
0/

•

.0--

~

0

~

z

w
u

a::
w
a.

40
• FROM ACETATE-I-C'4
o FROM MEVALONATE- 2 - CI4

20

2

4

CONCENTRATION

OF

6
TOLBUTAMIDE

8
(MIlIOI)

PIGURE 14
COMPARISON OP TftE EFFECT OF TOLBUTAMIDE ON THE BIOSYNTHESIS
OF CHOLESTER.OL FROM ACETATE-l-C14 AND MEVALONATE_2_C14

Conditions: For aeetate ... l-C14 - each flask contained 0.5 ml of
rat tIver homogenate (600 U\g of liver); 1.8 pmoles of NAD and
NADP, respectively; 3.3 iUDo1e. of ATP; and 20 ~ole8 of acetate
(0.5 ""C of 0-14). For mevalonate-2-0-14 - the conditions were the
.ame as in Table 8. Aerobic incubations at 37·0 for two hours.
Each point is an average of five experiments run in duplicate.
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TABU'! 9
EFP'ECT OF PHENETHYLBIGUANtDE

(lit

atOLES"lEROL BIOSYNTHESIS

FROM }fiWALONATE_2_C14

Conditions: the conditions were the same as deacribed in Table S.

•

I

Conc. of PbeJ\ethylbigwmide
M

x 10'

Cholesterol
41gitvadde
cpa/tug

~

Inhibition

NONE

2,380

0.5

1,102

28.5

1.5

1.224

48.6

3.0

832

65.0

4.0

528

77.8

5.0

556

76.6

6.0

524

77.8

p
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cholesterol bioaynth.a1a to .pproximately the s ... extent
(F1pre 15).

this is in contraat to _at vaa observed with

acetate-l-C14 a. the precursor of eRole.terol.

In the acetate

syat. ., pbenetbylblauanlde inhibited the incorporation of
acetate-l-C14 into cho1••terol to a Id.per dear. . than did
tolbut.-1c:1e.
Apin, .s .aa observed with to1buta1de. the max11lla

1Dbibitioft obta1aed with phenethy1bisuanide Wben aeva1onate-2-C14
was ",eel .. the star-tina ..Cerial is lover than 1ItIh. ac.tate . .s
uaed (J'iaur. 16).

In c.traat with to1bu.t_id•• the L.1bit1ou

... 20l loRr, or twice as much .. the deer.... 10 1Dhiblt1on
obta1Ded with tolbut_ide __ ....lout.-2-C14 and acetate-l-

e14

are

COIIp......

Wben th. tot.1 aoca-aapoa1f1ab1. lipid ... d.terat.Ded,

it v.a found 'that tolbut.tde, ch1orpropaaide. ad _tah__ld.
(2.5 x 10- 3 K) bad practically

DO

.ffect

OD

the lacorpol'atioD of

JlllYaloaau- 2_e14 iDeo the raoo-aapc:tIlifiabl. lipi.d fraeti., but
the fomat:l.Ola of cllol..tenl ... atill . .'r......

~"'._lde (2.5 • 10- 3 )I). _

a.-layl-

dua 0CIa_ 1aaDd, iDbU,it" the

1DcorporatioD of .avaloaate-2-e14 iDto both claol. ., ...l aDd tbe
total aoa-.apoaif1ab1. 1i,14 fraot1oD to approx:lNt.ly tb. . . .
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FIGURE 15
COMPARISON OF THE INHIBITION OF CHOLE..<)TEROL BIOSYNTHESIS BY

14
TOI..8U'tAMIDS AND PHENE'1'RYLBIGUARIDE nOM MEVALONA.TE_2_C

conditians: the conditions were the aame aa described in Table 8.
tOlbutamide - !p!u circlea: lDh.iEach point: l a an iverage of fi".
experimeilts run in duplicate.

~lo.ed ctijl~! IDhibition by
liii"iia"Di phiiiithylbi~nide.

p
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FIGURE 16
COMPAP.l3ON OF THE INHIBITION OF CHOLESTEROL BIOSYNTHESIS BY

PHENETHYLDlOURIDE FRCItt ACETATE_i_e14 AND MEVAl..O.NATE-2_C14

Condit1oua: the conditions were the aame as described in Figu.r:oe 14
Each poriit 1& an average of four exreriment8 run in triplicate.
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extent as shown in Table 10.
Popjak . . .11. J (115) and Lan&don and Bloch (86) ..-n&

others have found that the no~8aponlf1abl. lipld contaiDa all
the cboleaterol iDt8t'Bl8Cliat.. frOID a.alena to cholesterol

iDclualve17.

Alao. 1f mevalooate 1.

U8ed . .

the precur.or of

chol..terol bioe7DtluI.1a. the oral,. raclloactlve CCJIIP'OUl'lds pna_e

1a the ....sapon:1f1able 11p1d fraction are cholesterol intermediat... the htaheat amount of radioactivity appear1D& in

aqual.e.

the 1acorporatlOl'l of mevalemate- 2_C14 toto the

DOD-

.apooiftable fraction. therefore, could be taken .. an ..twee
of _qual. . s7Dthes1a •

Ie would . . . fr. the r.sults obtained 10 Tabla 10,
chat the uyllulfonylurua do DOt bahibit .,It of tha iDter. .lat.. of chol..t.erol 1alolyoth..la cOllta1ned in the GOD-sape"d.-

fiable lipid fraction.

Pheutbylld.panlde. however. . . . . to

1Dhl'Dlt the fonation of 1101' lnt._ecU..ac_ of ohol..t.uol la

thia fractloo t.o approdMtely the s _ extent as ahOWD by the
....., of chol..terol foe.. and the incorporation of ..valonate2_Cl4 into the non-saponifiable lipld.
Taktna the radioactlvity in the ftOD-saponifiable I1pid
fraotiorl .. a

rouP

indu of . .walene .ynth•• ia t it va. polta·

jii>

78
TABLE 10

EFPECf OF HYPOGLYCEMIC COMPOUNDS ON THE INCORPORATION OP
MEVALORATE_2_014 INTO THE NON-SAPONIPlABLE LIPID FRACTION

ConditiOha: the conditions were the same as described in Tab~ 6.
The 'concentration of all &ypoglycemic con:apounds was 2.5 x 10- H.
Aerobic tDcubatioaa at 37 C for one hour.
• Non-saponifiable lipid.

NSL*

,. Inhibition

cpa

NONE

(cpm/mg)
Sterol
di.gitonide

~

Inhibition

5,260

PHENE'fttn.-

BIGUAKIDE

41,990

2.160

41.4

TOLBUTAMIDE

73,860

5.0

1.970

62.5

MIDE

71,060

8.6

2,730

48.0

METAHEXAMIDE

12.290

7.0

CHl..oRPROPA-

.....
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lated that the inhibition of cholesterol biosynth••is from
mevalonate-2-C14 by phenethylb1&uanide should take place before
the formation of 8qualene.

l'he inhibition of cholesterol oio-

ayntheais by the arylsulfonylureas. on the other hanel. should be
after the formation of aqual.e.

To tut the above hypothesu. the first of the experiments performed to elucidate the aite of the inhibition of
chole.terol b1osyoth..la by the hnoilyc.u.o cQlBPOUDda, wa a

study of CIte effect of thue cOIBpOUDda on the first thr.. steps
of cholesterol a1fttheai. froa aevaloaate.
CarboD-l of .valonic acid 1. lost .. CO2 in the pathway to choleaterol by tbe formation of iaopentalyl pyropb.o.phate.

If aval_ie acid ... to be labeled in the l-position. the radioactive carbon dioxide obtained fna the incubations would aerve
as

aft

1ndicat1ou of the formation of uopentenyl pyrophoaphate

and the reactlou that prececle it.

whether or

DOt

'l'hia in effect would indicate

the hypoSl,c.uc COIDpOUDda bad . y effect on the

fomat:l.on of 5-pho.phoaevalonate. 5-dipboaphomeva1onate. and, of

cours., laopeDtat,l pyropboapbate.

10
Mevalon4te-l-C14 ... therefore incubated with 1.0 .1
of the dialyzed .olubl. . .yaea, ATP, and the hypoalyc.u.c compounds in concentrationa known to inhibit the bioaynthes18 of

Cholesterol almost completely.

Microsomes and the other cofactor.

nee.sury for chole.terol biosynthesis vere not uaed since they
are not: aeetled for the fol'llAtlOD of iaopeatenyl p)'rOpbo.pbate.
il

Tal. 11 ahow that none of the hypoalyc.uc cOllpOUrlds that were
used :I.n the inveati&at1on had any .ffect on the decarboxylation
of mevalonate-l-C14 as measured by the r.l.... of radioactive
carbon d1ox1de.

The ruulta of thia exper:laant indi.cate that

the bloa1Dtbea1a of choleaterol is DOt interrupted before the

formation of laopentenyl pyrophosphate by tolbutaicle, chlcn-pro~de.

or phenethllbiauan1de.

TD J1ICORIfOIt.A1'IOlI

or

MlVALOMU-2-C14

urro

THE lSOPUllOL

nao-

PHOSPHATES AND RELATED OOMPOUNDS

After ineubat10n of lHValonate- 2-c14 with the neceaaar,

cofactora aerobically. the iaoprenola, pre-aqualene braached
chain alcohol intermediate. of choleaterol, were iao1ated hy the
method of Popjak (116) given in the previous chapter.

The re.ult

in Table 12 ahow that one of the hypoalyc.u.c compounds,

ph.ethy1biau_ide, produced an iller.... of radioactivitY' in the

II

II
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TABLE 11
EFPEC'J.' OP HYPOGLYCEMIC CCH?otJNDS ON THE DECARBOXYLATION
OF MEVALONAn-l-C14

Ccmditi01UJ' Eaeh incubation flask cOfttained 1.0 ml of dlalyze4
solu61. . .,... (16.4 nag of protetftl, 10 ...,1.8 of A~ t a'Dd 0.5
paole of . .alO1Ul~. ('87,000 cpm). 't~ ccmcentration of the
0
hypoglycemic eompouads was 4 x lO--:M. Aerobic incubationa at 37 0
for 30 adnutes.

pmolea of e14
released as CO2

Hypoglycemic Compouad

NONE

32,500

0.085

PlIENETHYLBlGUANIDE

32,750

0.085

TOLBUTAMIDE

30,800

0.081

31,800

0.083

"

I

I

!,'
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TABLE 12

EPFEC1' OF HYPOOLYODf1C COMPot:JHOO Ott THE FORMATION OP
14
ISOPRENOL PYROPHOSPHA'l'ES FROM MEVALONATE_2_C

Oonditicma: the COI\ditions were the aame &$ described in Tab~ 8.
acmeeavation of the Itypoglycetdc cOl'lpOUl\ds was 2.5 x lO- 1,1.
Aerobic incubation_ at 31 C for two hour••

S

Hypog1yc-.ic COmpound

NONE

PHENETRYLBtGUANIDE

Sterol eli-

gitonide
cpm/mg

phosphates (cpm)

11,960

3,360

6,320

10,040

3,370

TOLBUTAMIDE

arLORPROPAMIDE

Iaoprenola fl"OlU
isopreno1 pyro-

7,350

3.100

6,020

3,870

isoprenol fraction.

Tolbutamide, chlorpropamide,

ana _tabexa-

mids. on the other band, had no effect on the incorporation of

mevalonat.... 2... C14 into tMa fraction.

1bi.

WaG

not an unexpected

reault, a:i.nce :i.t was postulated that phenetbylbigu.an.ide 1nh1bits
chol•• terol biosynthesis before the forut1on of equal.e, while

the arylaulfonylu.reaa 1ah1bit aft.. Che fcmaa't101l of 8flU&l.ao
!he ruulu in Tabla 12, therefore, comply with the hypotheau.

l"he fiDal proof of tills postulation would be to show

Ii

decr....

in the format1oll of _Qualm. w1th pheoetbylbisuaD1de wlUle

ohtaiumg the . . . format1oD of squalene with the uylaulfonyl-

ur....
10 t:be elucidation of the pathway of cholesterol
b1087Dthu1a. PopJak.lS.&1.. (11.5) fouad that _ _

1D~ioIUI

c:oDta1Diaa all the cofactors nec...ary for the, formation of
choleatarol . . .e 1ncubaed aerobically 10 the prueoce of re-

duced alutatb10De (GSH) both equal. . and cboluterol were
ayntba1aed from lleValooate- 2_c14 •

In the ab...ce of alutaCh10De

and in the prea.ce of oxygen. howver. neither squalene nor
cholesterol waa formed.

OIl

the other hand, UDder a nitro_

at:8Jsphere, aqualeD. V&8 8yathea1aed as efficiently in the

absence .. in the presence of alut.ath1oae.

10 fact, squal. .

84

waa the ooly radioactive intermediate formed in the non-saponifiable fraction wben incubations were done anaarobically.

Anaero-

bic incubations. then. stop the b10synthetic pathway of chol.....

terol at tba .formation of squalene.
In order to teat the hypothesis that the 1nhib1t1on of

<:bol_terol biosynthesis by tolbuta1de takea place before tbe
forutiOlt of squalene. wh11e the inhibition by phenethylb1panide

after the formation of aqualene. similar incubations were made

with the h7PO&lycem1c compounds.

After the specified period of

reaction in a nitro&en atll1Osphere. the non-saponifiable aubstan...

were extracted .. deacr:l.bed previoualy, and the squalene vas
separated from the re.t of the non-saponifiable lipid by ahml1u
c.hromatoaraphy.

the resu.lts in Table 13 abow that the fcn:aatlOll

of squal.ut 1n the preaenc. of phanethylb1&uan1de vas substan-

tially :l.ahibited.

In the preaence of the arylaulfonylurea eGa-

pounds (tolbut.ude and chlorpropamide). however. the formation

of .....lene was the . . . as in incubationa that contained

DO

hypoalyc-.ic compound.
To teat that squalene 18 the actual compound tb.at was
obtained, the elu.ted sample. were further characterized throuch
the thiourea adduct.

To the chroaatoaraphed specimen. after
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TABLE 13

EFFECT OF HYPOGLYCEMIC C(»IPOUNDS ON THE BIOSYNTHESIS 01'
SQUALENE FJ.\OO MEVALONA'l'E_2_C14

conditiO'hS: the conditions were the same as described in Table 8

with t'tii exception that no glutathione was present and that only
0.15 ""C of 0-64 was used. Anaerobic ineuba:tiona (ninogen atmosphere) at 31 C f_ one hour.

1

Hypoglycemic COmpound

NSL*
cpa

39,100

Squal• •
isolated
by al.umiM
cpm

29,690

urea a4duct
opm

29,320

16,980

29,160

TOLBUTAMIDE

39,000

* Non-saponifiable lipid

26,800

,

Squalene
after thio-

26,430
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evaporation of the solvant, a few ailliliters of a saturated
methano11c solution of thiourea, a few araina of finely powdered
t.'liourea. and 10

tUg

of carr iar squalene va added.

After thor-

ough. shaking. the mixture waa left at room taaperat.W:"8 for a f_
days.

lb. crystals of the clathrate were then filtered and

decomposed with water t the squalene extracted with petroleum

ether. and counted in a scintillation counter.
From the reaulta in Table l3 it can be seen that there

was no appreciable 10s8 of radioactivity after the aqualen. . . .
taken throuah the thiourea adduct.

'I'he coapouw;I that was actWl11,

be1nS eluted by petroleum ether from the alumina columna aad
assumed to be conaiatina of only squalene waa indeed equal_.
The 8ame table shows that asain pAaoethylbiauanida . . . in incu-

bati0D8 that ware allowed to proceed to chol•• terol, 1nbibited

the incorporation of mevalonate-2-C14 into the DOn-saponifiable
lipid fraction.

As in previous experiments. the arylau.lfonyl-

urea. had no effect on this fraction.
When the 1soprenols were iaolated from the anaerobic
incubationa,
incubation..

aaa1n

the same results were obtain.d as in .erobic

The data in Table 14 show that tllben plum.thy1-

b1&uanide we pr..ent. there

w..

an 1ncr.... in the 1ncorporatia
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TABLE 14

EFl'ECl' OF HYPOGLYCEMIC COMPOUNDS ON THE INCORPORATION OP
...iEVALONATE .... 2_C14 INTO ISOPRENOL PYROPHOSPHATES IN ANAEROBIC
INCUBATIONS

Conditions: the conditions were the same as described in Table 13.

'l'bi concentration of the hypoglycetd.c ~ wla 4 x 10-3 M.

Anaerobic mcubatt_. (nitrogen atmosphere) at 37 C for <me hou.r.

Hypoglycemic CoIapound

Squalene
cpa
•

NONE

TOLBtrrN-11DE

23,750

3.350

14,310

'.270

24,230

2,950

21,1140

3,360

b
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of lMValoaae.e-2-C 14 iDto th1. neutral fraction.
v.. pr. . .t

t

When tolbutamide

however. no difference MtweeD tlle control and the

uperiMntal 1rlcuat101l8 could H 00"".0.

FrOID tbe reaulta 80 far 4i8eu••ed 1e. i. 8een that _ _
pheDetb,lb1panid. 1s pr•••t in the incubatiotM. there 18 a
cieer.... iD the foraatiOl'l of 84f.\141ene. _
foraaac.1on of the i.,reG01•• an4
of MValoaate-l-C14 •

1\0

increase J.a the

effect oa. the clecarbox,l&tioa

'I'b.. ary18"1£oa,lUor.... llowever. bad

DO

efiece. OIl 8itA_ tile foraat;i.oD. of squal... the iaopr-.ola" or
iaopelltc,l pyropboaptaat..

'roe theae result., therefore, it i.

clear the pbeneth)'ll»ipaaide iDbJ.bita the bio.yDth. .18 of ehol. .terol fr_ ....loDate-2-C14 between l8opent_,l pyroplto8pbate aad
.,ual~••

while the ary18ul£oa,lur... 1Dbibit cholesterol b10-

xyDth. .1a after the forutiOD of squal...

l'he hypoth. .1a that

the 1Db:1bltion of choluterol bio81'1ltAeaiS by pbaethylb1paa1cle

18 before the formatioD of 84U81eoe and by the arylaulfonylur. .
co.pouncia after the fOnlAtlon of a. .1... ..... therefore. exper1MDtaI1y proven.
The further .lucidat1oD ef the sie.e of 1Dblbit1oa of

cholutero1 ld.oa)'Dth..1a by the h7P0alyc-.1c co.pounda ... done
with only two C08IpO\mds. tolbut.aa1de. an ary1au.lfODy1urea. and

19
ph.eth,lbiguaaide.

The other two ar,lsulfonylur... , cblorpro-

paaide and _tabexaide, were DOt uaed since it would DOt s _
likely that they would have a dUferent re.ult frOll that of
tollNt_ide.

this is in

ear_at

with tbe workers in the hypo-

Ilyc. .ic fleld who found that the only difference between the
varioua arylsulfonylureas ls the potency 10 reducins blood suaar
l..,els.

1D atrapancreatic studi.. J no difference, to this date J

between the ar,lsulfonylurea co.pounds h.s been observed.

THE SITE or THE
BY TOJ.JIOTAKll)E

.m VIm

UHIBITIOIt

or

CHOLESTEROL BIOStMTHESIS

When ..valonate-2-C14 is incorporated into chol. .terol
b, liver tu.G,enates or llver . .,.. syst_. OIle of the labels
fre. .."alonate-2-C14 18 found to r .. ide in one of the thr. .
. .thyl &roups of lanosterol not pr..ent in the cholest.rol
.,lecule.

e140 2

When laoaterol 18 decarboxylated t one .,lecule of

is obtdDed for

.,er, .,lecule of

lanosterol decarboxylated.

The theoretical ratio of the yield of labeled cholesterol to

labeled (Xl2 1s .5:1. an4 this value baa been approached by tbe
actual expert.eDtal value (16) (17).
SiDee tolbutaaide inhibits chol..terol biosynthesis
after the foraetion of ....1••• the

c140 2

obtained ire-. iDCU-
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hat-ions with mevalonate .. 2-c 14 was collectecl

B&c 140,.

al1d

determi.ned

a8

table 15 abovs that tolbutamide inhibits the decar-

boxylation of lanost.erol approximat.el.)' to the same QQ6l'ee as it
iPhi.bi.ta the formation of cholesterol.

However J this could not be

the polnt at. whic::h the inhibition take. place.

If the decar-

boxylation of lanosterol 18 1nh1b1ted by tolbutamide .U£ J.!. f.t
~t

be expected that there would be an accumulation of lano-

sterol in the mixtures containin& tolbutamide.

w..

the case,

DO

However J if this

observable inhibition of cholesterol should be

observed aince both lanosterol and cholesterol are precipitated
by d1a1tonin. which 16 specific for 3-beta hydroxy steroids.

In

other wrda. aiDce both lauoaterol and clloleaterol are precipitated by dijitooill. the decrease in cholesterol biosynthesis

'WOUld be counteracted by the accumulation of lanosterol. and no
difference in the diaitonidea would be observed.
ia DOt true.
~~.

This. of cour•• ,

Almost every table so far preaentad showed that

waa a deer.... in the di&iton1n precipitable material

wtaeaevc: tolbut4laid. wu preaent in the mixture.

The inhibition

of cboleacerol could DOt. therefore, take place at the decarboxy1at1on of laosterol.

It would 8e_. therefore, that the

iDb1b1t1oa of cholasterol biosynthesis from a.valonate-2-C14

Iii
11'11

liIi

.....
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TABLE IS
EFFECT 01' TOLBU'rAMlDE ON THE PORMATtaf OF CO

2

FROM MVA_2_014

Conditions: the conditions were the same as described in Table

wIth the excepti_ that 0.76 tJ.C of 0-14 waa used. 1'he
tration of ~lbu.t_ide was 4 x

for two hours.

lo-3M.

Aerobic incubations at 37°C

T

COntrol

NON-SAPONIPIABLE

LIPID

106,750

cpm

Tolbutamide

93,170

12.7

365

82.1

128

79.1

alOLESTEROL

DIGITONIDE

609

a

COl\C81l-

.....
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by tolbu.t:aIIlidc is at the cycllzation of squalene.

The proof of

this tJ.lgh.t well be provided by the ntudy of the incorporation of

mevalonate ... 2-C ~ into lanost(:lrol with and without added tolbuta-

tude.

This, however, is not a simple ta.sk.

In normal incu-

bat ions , as soon as lanosterol 18 formed it is metabolized alaoet

instantaneously.

The proof of the site of inhibition by tolbuta..

mide could not be done by the use of l:egular incubations sineG

only traces of lanosterol can be found.

Any changes observed ill

the fonnation of lanosterol would not have any significance.
The work of Moller and Tehan (l07) showed a way to

circumvent the difficulti.s that would aris. in the study on th.
incorporation of mevalonato-2-Cl4 into lanosterol.

They have

found that when mavalonate-2-C14 was incubated under aerobic

cond1tiOllS with rat liver homogenate. and the proper cofactor.,
substantial amounts of labeled carbon dioxide were formed.
Addition of arsenite inhibited the formation of labeled carbon
dioxide without affecting the yield in labeled non-saponifiable
lipid.

Cbromatoaraphy of the non-saponifiable lipid material

revealed that over 9a.r. of the label was aasociated with the
sterols J and that very little c14 was present in the squalene

r~!il
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Since the coQveratoa of ..valonate-2-C14 to lano.terol

fraction.

wulel DOt &1ve riaa to labeled CO 2 ,

"81''''

the formation of

chol•• terol Mould be accGaIpal\ie4 by the foraatioD of radioactiv.

earboD d1oxide, it appeared 11kely that tbe labeled product v ..

laBOstarol.

l'h18... coaf1ned

.y

the fo1low1na ev1cl_ce.

Vb_

labeled .....1. . . prapared by inc"'ti. _v41oaata-2-C 14 vith
rat 11ver ....,....t. ua4er . . . .01»10 COD41tiooa. v.. 1acuhated

with rat I1ver

II1cro.~

_d aolub1e ,roteln., Nth labeled

aterol ad laMled C0 2 . .zoe fonaecl.

'lb. addition of ar• •lte

. .lubed the fOl'll&tlOD of CO 2 v1tbout a!fHtiDI the 71e1. of

aterol.

Vb_ the labeled .t. .l, obta1De4 ill the , ....eDea of

..aardCa, . a racryaCal11aecl with chol.. tarol, the oqata1a
ODCa1aed after two recrYltailiut10Ba had no radioactivity.

Wba

the l ...lad aterol "aa recry.tal11aec1 with 1....ten1. the radioactivity r_iaecI vith the cryatala ale_ thr. . recryaealltaa-

tloDa.
. , ,Z'.1I'lcubatioa of th. liver _1M ayle. vlth
8rlal1ee, tha effact of tellJuc.-1ct. em the 1Deorpor.ciOll of

. .aloaate-2-C 14 iato laDoat. .ol could be 8Cudt.cl.

by cD_

tluat would be ob.erved uader th... eoad!t!• • wulel reflect tbe

effect of tolbutamide

OIl

1. .lt.o1 bi..,.dl..1a.

p:z

The liv.r _ , . .

.y.t_,

capabl. of ')"Ilth..1a1aa

chol•• C.rol aDd men. . . . , va. fir., preiDcubatecl with 10. 3 M

ar••it. for ... bour at flOC.

After the pr.iDcubat1cm period

" .. ttmd.Dated, aevaloaat.. 2-C14 , .terol

.u.

(4

II

eoeDII:r-a.

aDd colbu.ta-

10. 3 It) .......... and the aixtura ... tneubat." .t

3~C for t:.wo

hour..

!b. react1. . . . . . . . th_ .toppM aM lb.

• .,..U....l. ltp'd extr.cted.

1IOft-

'lb. '-beta hydroxy aterolc1a were

tbeIl precipltated by dl,lcoa1a after .wltl_ of traea _ _c.
of _label_ lao.terol ... chol.atarol.

Th. " ••lte 1. Tabl. 16

.law tbat laBOlt. .l for.atioa f r . MfA_2.e14 1a iDb1bit" by
toUNt_leI. to tha _

exper1aeaca.

ac_c ..

chol. .te'l"Ol . . . ia the

!b. cabl. _ _ .lao that CO

2

prev'_

product1oa 1a .lao

1abu.:1t.s .or. by tolbutaid. aad ar.elt. ChaD by arHD1t. .1....
Siac. . a . l t . 1Db1t.1ta tbe • ......,latloa of

1_-

aterol, lt abewa chat __ tol_taid. :1. alao pru.t, the

.ffect 1. a.alatl'M, 1 ••• t t01but.-1•• ad . .e.lta 1ab1blt the
deearboxylatioa of 188O.t..ol .... tbaa ...ait. dou aloae.

The

decr_. f.D th. r.l.... of CO 2 11, co1buc..td. 18 du. of coura. to
the d1ld.aiahed aval1a'bl11ty of l . . .tarol clue to th. 1ah1blCioa

of the cycl1aatioD of . . .1• • (deer _ _ 1_at.rol productloa
.. abowD 1D Tabl. 16).

Are.it.,

OIl

the otbar bad, 18 a

.....
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TABLB 16
EFFECT OF TOLBUTAMIDE 00 THE FOlt.'\fA'.rION OF LANOSTEROL FROM

MEVALONATE_2_C14

I

Conditiona: same aa in Table 8 except that each flask was gretiiCULatact With 0.001 M araenite and the enzyme syatem at 0 C
before the od\er additions were made. '1'he enzyme system ccm.tain~
23.4 mg of protein. The concp-tratlOD. of tolbutamide was 4 x 10'"
M. A.erobic ineubaticma at 37 C for two hove.

COntrol

Tolbutamide
opa

NON-SAPONIPlABLE

LIPID

LANOSTEROL

% Inhibi.ti_

46,800

43,770

6.5

1,820

459

74.1

169

18

'

'II

I

"

III,
"
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epec1f1c 1Dhibitor of the decarboxylation of lano.tero1, tarm1nat1Da the blo.ynthetlc pathway of ebola.tercl at lanosterol.
The proof that the COIIIpOl.1nfI obtained in this type of

an 1DcubatioD

wa_

laDOfItero1 and DOt cho1e.tero1 .aa aecoaapl1abecl

by one of the _thod. used by Meller aad reb_ (107).
. . . . that lIb_ the .tero1

wa. rec:ry.tall1aed twice with adcled

chol..terol, the erystal. obtained had practically _
activity.

Table 17

radio-

Wh.a the labeled .tero1 Val reery.talllHd with

1anoaterol, al.llllo.t all the radioactivity reaa1.necl with the
crystal. after two recry.ta111aatlon..
be

GO

'1'hl., of cour.e, .hou1d

aurprtae. .1I'Iee the _tbod u.ed for the .tudy of the in-

corporation of ..v.loaace-2-C14 tnto lano.terol

wa. that of

Moller aD4 Teb_. and it ehou1d be expected that the radioactive
coapound 1. .lated .hould be lanost..ol.

Tolbut.-1de. therefore, al.o iabibit. the fOr.ation of
lano.terol fr • ..valonate-2-C14 • Previoualy. it va• •hown that
.qual.e '1Dth.. ia va. DOt 1Dh1ltlted by tolbut_ide 18 anaerobic
iacuDat10aa (Table 14).

The

blo')'Ilthetic pathway, therefore,

B.l8t be interrupted by tolbutaide at the cycliutioa of

.qua1.e.

Thi. would iacU.cate that if the lncorporatioa of

aevalooate-2-c 14 ... allowed to proceed to cb01. .t.ol (aerobic

I,
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TABLE 17
THE IDENTIPICA1'1ON OF THE STEROL OBTAINED DUR.ING INCUBATIONS
WITH ARSENITE

Measurement. of 014

Control

cpm

Tolbutamide
r

Non-saponifiable lipid

2,l37

554

Original activity thought
to be lanosterol (.a the
digitonicle

668

173

After two recrystallizations
with lanosterol

572

l05

After two recrystallizationa
with cholesterol

15

10

Mil

98
incubations with the addition of alutachion.), an incr.... in the
fontation of . . .1... should be oNerved.

Previoua up___ ta

in which squalene waa i.olated were stopped at the formation of

aqual._ by utilising anaerobie iDeubation•• and a ••uch, no
dUfereaee betweeD the control. aad tolbut_ide ccmtahd,DI1I1xture. would be expected and were DArY'er obtained.
The re.ults in Table 18 show that if the Mtabolic

sequence i. DOt tendnated until ehol..terol 18

fo~.

ther. i.

a eonc.tn&nt incr.... in the formation of 'qual• • with the
drop in choleaterol syntb..1sed ill bacubatlou eoa.talD1q tol_-

t_1de.

Th. deer.... in chole.terol b1e.,.tb.al, _ . tol1Nta-

1If.de 1, added to the iftCUltationa can be accouatecl tor by the
increased produetlon of . . .1.. as .hown in Table 19.
The exper:1meDtal data 8bowa that tolbue.1de 1Db.f.bit.
the fOJ.'MtlOD of both ebol.aterol and laao.terol. but iller.....
the formation of equalene.

Ther. ia no dou'bt, therefora. that

tolbutamide inhibits Cholasterol bloayntb•• is fro. ...alooat.2_c l4 between aqualene and lanoeterol or at the 01e1ia8tion of

squa1.e.
THB SITI or THE 1I VIDO DHIBI'lIOll
BY PHEDTIYLIlGUAliIDE

or

CHOLESTEROL IIOSYWrHlSIS

I

I:

Data, previously dUcua8ed. abowel that phenethylbiIli\
!.I'II
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TABlE 18
EFFECT OF TOl.JSUTAMIDE ON THE roDiATION OF SQUALENE PR.OM

MEVALOKATE_2_C14

Conditions: the conditions were the same as described in Table 8
WlMi Bie 'DOted. exceptiona. The concentration of tOlbgtamide wea
2.! x 10-3 M. All i'ncubationa were carried out at 37 C for two
hours.

Type of Incubation

ANAEROBIO*

Measurements

of 0-14

Tolbutamide
cpa

NSL

31.100

30,600

SQUALENE

29,690

30,290

o

o

172,360

157,520

CHOLESTEROL

AEROBIC

control

NSL

'I

, ,
I: ,

120,100
CH<JLESTEROL

*

60,500

37,000

Glutatbf.ofte was not preaent in the incubation mixture i1\ aueroblc iacubati.cma.

I '
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TABLE 19

EFFECf OF TOLBUTAMIDE ON THE INCORPORATION O'F MEVALONATE_2 ...C14
INTO THE TOTAL NON-SAPONIFIABLE LIPID, SQUALENE, AND alOI.,E...

STEROL

The number of micromol.. of mavaloaate incorporated into the
different fractions was calculated from the results in Table 18.

Measurements of 014

Control

To1but~ide

IJ.lIDlea of 'MYA

ineoJl'pOr'ated

Total non-aaponifiable lipid

0.224

0.212

SQUALENE

0.134

0.161

+ 0.027

CHOLESTEROL

0.082

0.046

... 0.036

Squalene + Cholesterol

0.216

0.207
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auanide decrea.ed the for.ation of .qualen. and incr••••d the
formation of the i.oprenol..

Thi• •

u"••

ted that th. inhibition

.a. at th. i.opreno1 .tq. in th. bio.7Dth•• i. of chol•• terol.
To obtain further support for this .it. of tnbibitioD. incubationa were .tarted without th. addition of ticro..... to th•
• yet...

Thi. o.i•• loo .topa th. bio.1Othetic pathway at th.

C15-18opreo1 pyrophosphate. fameao1 (63).

At th. end of th.

fir.t hour of incubation ••oae reaction. vere stopped by lOB
aocI the i.o,reool fr.ction _tr.cted and analyzed.

To . . . of

the other be• •tiOD.. 0.2 a1 of aicroaa.ea ... acklecl. _il.
other. ..... l.ft without aicr......

The 1ncubat:l.oa. . .e th_

allowed to proceed for another hour.

At the end of the .ecood

hour the reactiooa were .topped and the i.opreaol fraction
anal)'11ec1.
The data in Table 20 .bows that when the ticro. . . .
were o.itted fl."Oll the iIlcubatloa IDixtur... the fo....tioo of the
iaopreaol. fro. . .v.lonate-2-C 14 in both control. and incubations
CODtainiai p"-t.thylbipalde were th. s _ .

.ether tlle 1Rcubatlon period va. ODe or two

Tbi• •as true

bour..

Th. ineor-

,oratlOD of . . . .lonat.-2-C14 1nto the isopranol fr.ction after
two hour. was aucb b1&her than .ft.r on. hour. but DeYerthel...
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TABLE 20
EFFEC'1' OF PHENETHYLBlGUANIDE ON THE FORMATION OF ISOPRENOL-

PYROPHOSPHATES FROM MEVALONATE_2_C14

Conditiona: Each flaak contained 1.0 m1 of dialyzed soluble
ens".s (1:8.0 mg of protein); NADB (2 i£IIOles); NADPH (1 ....le);
A'tP (30 J.LIDOlea); reduce.d glutathione (30 lJlDOlea); MgC12 (16
iJlUOlea); MnSO~ (4 ..,molea); and meva~c acid (0.5 ..,mole, 0.25
~C

of 0-14). Aerobic incubations at 37

Syat_

Time of
incubation
hours

c.

laoprcmol Pyrophosphate.
eotrrR.ot.
PHENETRYLBIGtJANIDE
cpa

Complete.
System

1

20,800

COmplete
Sy.tam

2

42,600

2

17,500

20,200

Complete
System .. microsomes added after
1 hr. In.cubationa coatlnued
for an additional hour

45,550
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the same for both controls and phenethylb1guanide containing
incubations.
If microsames were added at the end of the f1r.t hour,
the isoprenol pyrophosphates in the controls were further
metabolized to cholesterol as evidenced by the deerease in radioactivity after two hours when micros01D8s were present (Table 20)
and tbe appearance of synthesized cholesterol (Table 21).

In-

cubation. containing pbenethylblsuanlde, however, had the __
amount of radioactivity as.ociated with the isoprenols whether
the microlomes ware added or DOt.

Th. cholesterol formed in the

phenethylbiauanlde containing incubation. when the mierolOMs
were added va. much 1... than when phenethylbiguanUe was abIent
frca the incubation _dium (Table 21).

l1te enzymes contained

in the microaomu that transform the iaoprenol. into .qualene
and subsequently into cholesterol were unable to metabolize the
isoprenol. when pbenethy1b1auanlde was present.

This indicates

that the biosynthe.is of cholesterol from mevaloaate-2-C14 i.
interrupted by pheaethylblsuanide at some isoprenol.
In order to find out Whicb compound or compounds contained thi. b1gb radioactivity when pbenethylbiguanlde is

pre.ent, the isoprenoll had to be .eparated and identified.

Of
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TABLE 21

EFFECT OF PHENETHYLBIGU.ANIDE
CHOLEST&ROL FROM MEVALONATE-2_a

14

(II

THE BIOSYNTHESIS OF

IN THE PRESENCE AND ABSENCE OF

MlCROSC»ms

ConditiOl'ls: the conditions were the same as described in Table 20.

n

System

Time of
incubation
hours

CONTROL

PHENETHYLBlGUANIDE

Cholesterol
epm

Complete Syata

1

o

o

Complete System

2

o

o

Complete Syatem -

microsomea added

after 1 hr. Incubations contil'lUed

lor an additional

hour

2

10,020

810

q
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the

a\~

methods commonly used for the identification of these

compounds, gas-liquid chromatography and paper chromatography,

the latter was the more feasible, although more involved.
Dimethylallyl alcohol, geraniol, farnesol, and nerolidol cannot
be separated by paper chromatography as such.

The separation of

these compounds can only be done after a suitable derivative of
the alcohol function is made.
3,' ..d:1nitrobenzoate.

The derivative of choice was the

After many methods were tried, the method

of Cheronis and Entrilcin (33) was adopted and 1. liven in the

chapter on materials and methods.

Thi. method was ehoaen since

it gives good derivattvu of small quantities of not only primary
and secondary, but also of tertiary alcohols.

This i . important

since nerolidol, a tertiary alcohol appears in the fraetion that
was analyzed.

Figure 17 shows the radiochromatogr_ obtained from
the reverse ph... chromatography of the i8oprenol-3,5-dinitro-

benuat...
an It

f

There was a larae accumulation of a compound haviq

value of 0.32 in iDcubation. cont.iains phenethylbisuaaicle.

This eorreaponda to farn••ol and nerolidol-3,'-dinitrobenaoat ••
as shown by the movement of authentic sample. of the derivative••
A small radioactive peak was al.o obtained at the ortain which
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-

~~

"

, ,-", \

-~

GERANIOL

\

,

FIGURE 11
RADIOCH&OMA.TOORAMS

or THE lSOPIt.l!!H0L-3,5-DlNITROBENZOATES

Ra".rae phas. chroIutography an Yhatman No.1 paper imp~ted

with 10'1. medlum mineral 011. ne".lopmg solvent - 7S~ acettc acto.
To~:5r.~reproduction of a radiochromatograph of isopranol!
til
btmsoatea obtaifted from f:ncubatiOll mixtures - Broken
line - CONTROL; solid line - INCUBATIONS CONTAINING PHENETHYLIIGt1ANlDE. Pull aoale deflectlO1l • 100
Bottoat !a
reproduction of the separation obtained from 3.5-arftltro~nBoyl
derivatives of authentic aamples of the iaoprenols. The origin i.
at the rigbt; the solvent front at the left.

.pm.

e:
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a&ain waS

laq~er

in incubatiOtlS that contained phenethylbliU&Dide

as compared to the ones that did not.

'rhis is thought to be

free nuolidol t since authentic samples of free nerolidol stayed

at the origin in the system that was used.

Also, if the re-

fluxing during the making of the derivatives was increased from
one to

two

hours, the radioactive peak at the origin disappeared

and a concominant rise in radioactivity with an Rf value of 0.32
was observed.

In order to separate the farneaol and nerolidol-3,Sdinitrobenzoates, the solvent front waa allowed to run off the
paper.

By this method the two CLS -lsopreaol-3.S-dinitrobenzoat..

were reasonably separated.

The farnesol-3,S-dinitrobenzoate

came first and resolved into a sharp peak, followed by a larae
drawn out band of radioactivity corre.pondina to nerolidol-3,S-

d1n1trobenzoate.

The results in !'isure 18 show that the radio-

cbromatoaras of the isopreno1 derivativ.. frOli incubations
contain1D& phenethylbisuanide had an increased formation of
famesol and nero11dol .s eoapared to incubations in which
pbenethylblpanide was not present.

In order to obtain the

amount of radioactivity present in theae compounds. plan1metry

vas used to obtain the areas under the peaks obtained from the

II

I::
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III
II
! I

FIGURE 18

THE SEPARATION OF FARNESYL AND NEROLIDYL-3.5-DINITROBENZOATES

Reverse phase chromatography on Whatman No.1 paper impregnated
with 10~ medium mineral oil. Developing 101vent - 75% acetic acid.
TO~ ~ra~h: reproduction of a radiochromatogram of isoprenol3, - in trobenzoates obtained from incubation mixtures - Broken
line - CONTROL; solid line - INCUBATIONS CONTAINING PHENETHYLBIGUANIDE. Full scale deflection = 250 cpm. Bottom ~raph:repro
duction of the separation obtained from 3,5-dinitro enzoyl
derivatives of authentic samples of the isoprenols. The origin is
at the right; the solvent front was run off the paper in order
to separate the farnesyl and nerolidyl derivatives.
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reverse phase
a.tes.

~hroms.togrJ3.?hy

of the isopre:t101-3,S-dinitrobenzo-

Table 22 shows essentia.lly the same picture as discussed

above, except that the results are tabulated In terms of the
amount of radioactivity (cpm) present in the different isoprenola.

Allyl pyrophosphate.. in cc:mllon with other substances
in which a potentially anionic group is in th. alpha-position to
a double bond. are electrophl1ic compounds and can be expected

to lose the pyrophosphate ion rather readily.

lbe electron

deficient species resulting from the elt.1nation of the pyrophosphate ion, may be partially stahili.ed by resonance between
two equivalent forma <as discussed in Chapter I).

In the pres-

ence of water, the two forms may yield. by the addition of a
hydroxyl ion, either a primary or tertiary alcohol.

This is the

_chanin of allylie rearrangement, and vas found by Goodman and
Popjak (116) and Lynen .IS.

.t!..

(93) to be responsible for the

conversion of a large part of farn.sol pyrophosphate

to

nerolldol

during acid hydrolysis of the isoprenol pyrophosphate••
lbe nerolidol obtained 1n "lsure. 17 and 18, and in

Table 22. therefore, actually comes from the rearrangement of
fam.sol pyrophosphate durin, the iaolation procedure.

The

meaaurement of tbe radioactivity of both f.mesol and Derol1do1-

1,1
;1

I I

I:

I

"
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TABLE 22
QUAN~rITATION OF THE RADIOCHROMATOORA1'-1S OF ISOPRENOL-3,5-

DINITROBENZOATES

Figure

Subsunee

17

Ul\reacted

18

OONTROL

cpm

PHENETHYLBI GUANI DE

Nero1ido1

90

292

Nerolidol
+
Farneaol

118

944

Farneao1

100

1,423

9S

1,255

~Nerolido1

I,
"
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:3 t.5-d1nitroben~~oates is actually an indication of the radioactivity originally present in famesol pyrophosphate.

Phene-

thy lb lauani de , then, increases the formation of farneBol pyrophosphate.

From data previously discussed, it was seen that

pbeneehylbtsuanide alao deerea.es the incorporation of

mevalonate-2-C14 tnto squalene.

The site of inhibition of

eholeaterol biosynthesis by pbenethylbiguanide 1a J therefore J
between famesol pyrophosphate &lDd squalene J stopp1n& the bio-

synthetic pathway of cholesterol fro. mevaloaate at the C

15

alcohol pyrophosphate.

The action of the hypoalycemic compounds, tolbut..ide,
chlorprop..u.de, metabexamide. and pbenethylblauan1de, on the
blosynthesl. of choleaterol ba. been tnve.tl.ated Ja vitro with
aevalonate-I-C l4 uatna a rat liver enzyme sy.t... The r ..ult •
• how that the lncorporation of aevalonate-I-C14 tnto ebole.terol
18 inhibited by all compounda atudied.

The . .faal inhibition

occur. wben the concentration of hypoalyc..tc co.pound ia

4 x 10. 3 M.
The -.nner in Which the.e compound. inhibit chole.terol
bioaJllth.. i8, h01M'ler. i. qulte different.

Ph.ethylbipaaide

decr..... the formatioa of the noo-saponifiable lipid. aDd
choleaterol by approximately the .... ..ount fro. ..valonate-l-

el4 • Thi. would ~ly that pbenethylbiauanide 1nbibita the
bio.ynth•• ia of cholesterol before tbe for.ation of the cholesterol iftter.ediate found in the DOD-.aponifiable lipid fraction.
'l'hls i ••ubstatlated by the lDhiltitlon of .qualene for.atlon
froID ..valonate· l-e14 •

'urtber.re. there la an accuallatloa of

the isopreoola. pre-• •alene cholesterol tnterMCIiate..

Rever.e

pha.e cbro.atoarapby of the 3.5-diftitrobeaaoate derivativ.. of
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the .lcohol. showed Chat the accumul.tion of r.dioactivity ••• in
the fam..ol deriv.tive.

It follow that pben.thylhiauanlde

interrupt. the biosynthesi. of cholesterol at the level of the
Cu -isoprenol, farn •• ol pyropho.phate.
the aryl.ulfonylur•••• tolbutamide. chlorpropamide, and
••tabex..id., howev.r, .re different aa rel_rds their effect on
the bio.yntheai. of chol •• terol.

Th.y do not inhibit the incor-

por.tion of mev.lon.te-2-Cl4 into the non-••ponifiable lipid and
chol •• t.rol by the .... meanitud..

St.rtin& with mev.lonat.-2-

C14 • there is .bIo.t no difference h.tween the non-••ponifiabl.
lipid for.ed when the .ryl.ulfonylur.. compound. .r. pr•• ent or
absent from the incub.tion mixtur., and yet chol •• t.rol b10.10th•• i. i. inhibited.

When th. i.oprenol••nd .qu.len. are

iaolated, th.re aaain i. no diff.renc..

When, howev.r, lano.terol

was i.ol.ted, th.re . . . . d.cr•••• in its for.ation corr•• pondinl
to the deer.... obt.ined in chol•• t.rol .ynth.. is.d frOil
....lonat.-2-C l4 • And fin.lly, when squ.len. . . . i.ol.ted aft.r
.erobic incub.tions, th.r. . . . an incr•••• in it. fonaation when
tolbut..id. . . . pr•• ent in the incub.tion aiatur... Th. incr••••
in .qualen. formation from . .v.lon.t.-2-C l4 could b. expl.ined by
the d.cr.... in the biosynth•• i. of chole.terol in the .... in-
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cubations.

It follow., therefor., that tolbutamide inhibits
cholesterol biosynthe.is from mevalonate-2-C 14 betv.en squalene
aDd lanosterol, or more precis.ly, at the eyelia.tioa of squalene.
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APPE'NDL<

lrUar.tion of thea Bufftar .oluSion:
'The buffer solution uaed in all incubations waa prepared
as follow:

13.969 I of K2HP04 (AR, HalliDckrodt CheaDlcel Co.);

2.695 I of iCH2P04 (Ar, Mallinckrodt CIt_ical Co.); 0.978 i of
MaCl2.61120 (AR. Mallinckrodt Chemical Co.); and 3.664 I of
aicotinamide (lot 133'1, Nutritional Biochemicals), was .,d. up
to em. liter

ncb

doubly» ews distlllecl

".ter.

Tb.. final

molarity of the solution was 0.1 with re.pect to phosphate, 0.03
Ie w:ltb respect to nicotinamide, and 0.0048 M with respect to
The Pd, .s ....ur.d by a Beckman pH meter, was 7.4.

Mael •
2

Pltt!!'lDiytlon of hotey:
lbe prot.in contained in the enzyme .ystem was measured by

the biuret r.eaction (64).
follows:

The biuret reaaent was prepared as

0.640 I of anhydrous CuS04.SHzO (AR, Mallinckrodt

Cbeaical Co.) and 6.0

a

of DaC.Ht.06.4H20 (AR. Mallinckrodt

atem.cal co.) dissolved in about 500 .1 of water.

'ro this .,s

added 300 ml of lO~ NaOH and the solution was diluted to one
liter.

When this solution is added to prot.in solutions" •

viol.t color r.sults.

1.34
4 ml of the color reagent was added to the enzyme syst_
or atandat-cl.

The final volume of S ml was made up with doubly

distilled water.

After mixing, the color was allowed to develop

for 1.5 minutes slld them determined in a Klett colorimeter uaina
a '54 filter.

Crystalline albumin from bovine serum (lot Iw

69312, Armour Pharmaceutical Co., Kankakee. Illinois)

waS used to

prepare the standard curve illuatrated in Figure 19.

3tandardG

were alway. run atmultaneously with the unknown enzyme .yst....
lb. data used to prepare Figure 19 is pruented in Tabla 23.
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FIGURE 19
STANDARD CURVE FOR THE BImtET :?ROTEIN DETER.l>1INATION
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TABIB 23
STANDARD ClJRVE FOR THE BIURET PROTEIN DftERMIMA'l'tON

MG of PROTEIN

KLETT READING

0.5

11

1.0

28

1.5

45

2.0

SS

2.5

71

3.0

85

3.5

99

4.0

114

4.5

121

5.0

138

NO. 54 filter was used for the readings.
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TABLE 24
THE SOURCE OF CHEMICALS USEn IN '!'HE INVESTIGATION NO'!'
DESCRIBED El.sEWHERE

1). Aluaina, activated. 80-200 meatt. eu-atographic absorption:
Merck and 00., Rahway, H.J.

2). ADmcmium Sulfate, AR:

Mallinckrodt: Chem.ical

Co.,

New York.

3). Acetic acid, sodium salt, AR, lot #J'NA. Mallinckrodt

Chemical

Co.,

New

York.

4). Chole.terol, lot #5177'1
East: Rutbeford, N.3.

5). Digitonin, ARt lot
Inc., Hew York.

#

Mathea• • COleman and Bell 00.,

D 3046. Mann Research Laboratories,

6). 3.S-Dhdtrobeazoyl Ohloric1e. IB.p. 68-69°:
and Bell, East Rutheford, N.J.

7). Pa.m.esol, lot #8, Chemicals
College point, N.Y.

8). Geraniol, lot #35152 L:

N.Y.

p~t

Matheson. Coleman

Laboratories, Inc.,

K and K Laboratories, Inc., Jamaica,

9). Lanosterol, 0 grade, lot #106938: california Corporation
for Biochemical Research, Los Angeles, calif.
10). Neroltdol. lot #35884:

N.Y.

K and K Laboratories, Inc., ..Jamaica,

11). Sodium Arsenite, ARt lot #28108, J.T. Baker Chemical

Phillipsburg, N.J.

12). Squalene, lot /I A 5664:
New York, N.Y.

Co.,

Mann Research Laboratories, Inc.,
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